Adaptive alarm system

- MASIMO CORPORATION

Systems and electronic processes for reducing electronic alarms in a medical patient monitoring system. For example, a system for reducing electronic alarms can include an optical sensor and one or more hardware processors in electronic communication with the optical sensor. The one or more hardware processors can be programmed to measure oxygen saturation values of a patient over a first period of time, determine if at least one oxygen saturation value obtained over the first period of time exceeds a first alarm threshold, determine whether a first alarm should be triggered based on the determination that the at least one oxygen saturation value obtained over the first period of time exceeds the first alarm threshold, determine a second alarm threshold to be applied during a second period of time subsequent to the first period of time, the second alarm threshold replacing the first alarm threshold.

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description
PRIORITY CLAIM TO RELATED PROVISIONAL APPLICATIONS

The present applicantion This is a reissue continuation application, meaning it is a reissue of U.S. Pat. No. 9,775,570, and is also a continuation of U.S. Reissue patent application Ser. No. 16/184,908, which is reissue of U.S. Pat. No. 9,775,570 and a continuing reissue of U.S. Reissue patent application Ser. No. 15/881,602, which is a reissue of U.S. Pat. No. 9,775,570, issued on Oct. 3, 2017 and titled “Adaptive Alarm System,” which is a continuation of U.S. patent application Ser. No. 13/037,184, filed Feb. 18, 2011 titled Adaptive Alarm System, which claims priority benefit under 35 U.S.C. § 119(e) to U.S. patent application Ser. No. 13/037,184 filed Feb. 18, 2011 titled Adaptive Alarm System;Provisional Patent Application Ser. No. 61/309,419, filed Mar. 1, 2010 titled Adaptive Threshold Alarm System; and U.S. Provisional Patent Application Ser. No. 61/328,630, filed Apr. 27, 2010 titled Adaptive Alarm Systems; more than one reissue application has been filed for the reissue of U.S. Pat. No. 9,775,570, including U.S. patent application Ser. No. 16/800,971 (the present application), U.S. patent application Ser. No. 16/184,908 and U.S. patent application Ser. No. 15/881,602; all of the above-cited provisional patent applications are hereby incorporated by reference herein.

BACKGROUND OF THE INVENTION

Pulse oximetry systems for measuring constituents of circulating blood have gained rapid acceptance in a wide variety of medical applications, including surgical wards, intensive care and neonatal units, general wards, home care, physical training, and virtually all types of monitoring scenarios. A pulse oximetry system generally includes an optical sensor applied to a patient, a monitor for processing sensor signals and displaying results and a patient cable electrically interconnecting the sensor and the monitor. A pulse oximetry sensor has light emitting diodes (LEDs), typically one emitting a red wavelength and one emitting an infrared (IR) wavelength, and a photodiode detector. The emitters and detector are typically attached to a finger, and the patient cable transmits drive signals to these emitters from the monitor. The emitters respond to the drive signals to transmit light into the fleshy fingertip tissue. The detector generates a signal responsive to the emitted light after attenuation by pulsatile blood flow within the fingertip. The patient cable transmits the detector signal to the monitor, which processes the signal to provide a numerical readout of physiological parameters such as oxygen saturation (SpO2) and pulse rate.

SUMMARY OF THE INVENTION

Conventional pulse oximetry assumes that arterial blood is the only pulsatile blood flow in the measurement site. During patient motion, venous blood also moves, which causes errors in conventional pulse oximetry. Advanced pulse oximetry processes the venous blood signal so as to report true arterial oxygen saturation and pulse rate under conditions of patient movement. Advanced pulse oximetry also functions under conditions of low perfusion (small signal amplitude), intense ambient light (artificial or sunlight) and electrosurgical instrument interference, which are scenarios where conventional pulse oximetry tends to fail.

Advanced pulse oximetry is described in at least U.S. Pat. Nos. 6,770,028; 6,658,276; 6,157,850; 6,002,952; 5,769,785 and 5,758,644, which are assigned to Masimo Corporation (“Masimo”) of Irvine, Calif and are incorporated by reference herein. Corresponding low noise optical sensors are disclosed in at least U.S. Pat. Nos. 6,985,764; 6,813,511; 6,792,300; 6,256,523; 6,088,607; 5,782,757 and 5,638,818, which are also assigned to Masimo and are also incorporated by reference herein. Advanced pulse oximetry systems including Masimo SET® low noise optical sensors and read through motion pulse oximetry monitors for measuring SpO2, pulse rate (PR) and perfusion index (PI) are available from Masimo. Optical sensors include any of Masimo LNOP®, LNCS®, Soffouch™ and Blue™ adhesive or reusable sensors. Pulse oximetry monitors include any of Masimo Rad-8®, Rad-5®, Rad®-5v or SatShare® monitors.

Advanced blood parameter measurement systems are described in at least U.S. Pat. No. 7,647,083, filed Mar. 1, 2006, titled Multiple Wavelength Sensor Equalization; U.S. Pat. No. 7,729,733, filed Mar. 1, 2006, titled Configurable Physiological Measurement System; U.S. Pat. Pub. No. 2006/0211925, filed Mar. 1, 2006, titled Physiological Parameter Confidence Measure and U.S. Pat. Pub. No. 2006/0238358, filed Mar. 1, 2006, titled Noninvasive Multi-Parameter Patient Monitor, all assigned to Masimo Laboratories, Irvine, Calif (Masimo Labs) and all incorporated by reference herein. An advanced parameter measurement system that includes acoustic monitoring is described in U.S. Pat. Pub. No. 2010/0274099, filed Dec. 21, 2009, titled Acoustic Sensor Assembly, assigned to Masimo and incorporated by reference herein.

Advanced blood parameter measurement systems include Masimo Rainbow® SET, which provides measurements in addition to SpO2, such as total hemoglobin (SpHb™), oxygen content (SpOC™), methemoglobin (SpMet®), carboxyhemoglobin (SpCO®) and PVI®. Advanced blood parameter sensors include Masimo Rainbow® adhesive, ReSposable™ and reusable sensors. Advanced blood parameter monitors include Masimo Radical-7™, Rad-87™ and Rad57™ monitors, all available from Masimo. Advanced parameter measurement systems may also include acoustic monitoring such as acoustic respiration rate (RRa™) using a Rainbow Acoustic Sensor™ and Rad-87™ monitor, available from Masimo. Such advanced pulse oximeters, low noise sensors and advanced physiological parameter measurement systems have also gained rapid acceptance in a wide variety of medical applications, including surgical wards, intensive care and neonatal units, general wards, home care, physical training, and virtually all types of monitoring scenarios.

FIGS. 1-3 illustrate problems and issues associated with physiological parameter measurement systems having fixed threshold alarm schemas. FIG. 1 illustrates a lower-limit, fixed-threshold alarm schema with respect to an oxygen saturation (SpO2) parameter. Two alarm thresholds, DL (delay) and NDL (no delay), are defined. If oxygen saturation falls below DL for a time delay greater than TD, an alarm is triggered. If oxygen saturation falls below NDL an alarm is immediately triggered. DL 120 is typically set around or somewhat above 90% oxygen saturation and NDL 130 is typically set at 5% to 10% below DL. For example, say a person's oxygen saturation 110 drops below DL 120 at t=t1 162 and stays below DL for at least a time delay TD 163. This triggers a delayed alarm 140 at t=t2 164, where t2=t1+TD. The alarm 140 remains active until oxygen saturation 110 rises above DL 120 at t=t3 166. As another example, say that oxygen saturation 110 then drops below NDL 130, which triggers an immediate alarm 150 at t=t4 168. The alarm 150 remains active until oxygen saturation 110 rises above DL 120 at t=t5 169.

FIG. 2 illustrates an upper-limit, fixed-threshold alarm schema with respect to an oxygen saturation (SpO2) parameter. This alarm scenario is particularly applicable to the avoidance of ROP (retinopathy of prematurity). Again, two alarm thresholds, DU (delay) and NDU (no delay), are defined. DU 220 might be set at or around 85% oxygen saturation and NDU 230 might be set at or around 90% oxygen saturation. For example, a neonate's oxygen saturation 210 rises above DU 220 at t=t1 262 and stays above DU for at least a time delay TD 263. This triggers a delayed alarm 240 at t=t2 264, where t2=t1+TD. The alarm 240 remains active until oxygen saturation 210 falls below DU 220 at t=t3 166. Oxygen saturation 210 then rises above NDU 230, which triggers an immediate alarm 250 at t=t4 268. The alarm 250 remains active until oxygen saturation 210 falls below DU 220 at t=t5 269.

FIG. 3 illustrates a baseline drift problem with the fixed threshold alarm schema described above. A person's oxygen saturation is plotted on an oxygen saturation (SpO2) versus time graph 300. In particular, during a first time interval T1 362, a person has an oxygen saturation 310 with a relatively stable “baseline” 312 punctuated by a shallow, transient desaturation event 314. This scenario may occur after the person has been on oxygen so that baseline oxygen saturation is near 100%. Accordingly, with a fixed threshold alarm 330 set at, say, 90%, the transient event 314 does not trigger a nuisance alarm. However, the effects of oxygen treatments wear off over time and oxygen saturation levels drift downward 350. In particular, during a second time interval T2 364, a person has an oxygen saturation 320 with a relatively stable baseline 322. The later baseline 322 is established at a substantially lower oxygen saturation than the earlier baseline 312. In this scenario, a shallow, transient desaturation event 324 now exceeds the alarm threshold 330 and results in a nuisance alarm. After many such nuisance alarms, a caregiver may lower the alarm threshold 330 to unsafe levels or turn off alarms altogether, significantly hampering the effectiveness of monitoring oxygen saturation.

A fixed threshold alarm schema is described above with respect to an oxygen saturation parameter, such as derived from a pulse oximeter. However, problematic fixed threshold alarm behavior may be exhibited in a variety of parameter measurement systems that calculate physiological parameters related to circulatory, respiratory, neurological, gastrointestinal, urinary, immune, musculoskeletal, endocrine or reproductive systems, such as the circulatory and respiratory parameters cited above, as but a few examples.

An adaptive alarm system, as described in detail below, advantageously provides an adaptive threshold alarm to solve false alarm and missed true alarm problems associated with baseline drift among other issues. For example, for a lower limit embodiment, an adaptive alarm system adjusts an alarm threshold downwards when a parameter baseline is established at lower values. Likewise, for an upper limit embodiment, the adaptive alarm system adjusts an alarm threshold upwards in accordance with baseline drift so as to avoid nuisance alarms. In an embodiment, the rate of baseline movement is limited so as to avoid masking of transients. In an embodiment, the baseline is established along upper or lower portions of a parameter envelop so as to provide a margin of safety in lower limit or upper limit systems, respectively.

One aspect of an adaptive alarm system is responsive to a physiological parameter so as to generate an alarm threshold that adapts to baseline drift in the parameter and reduce false alarms without a corresponding increase in missed true alarms. The adaptive alarm system has a parameter derived from a physiological measurement system using a sensor in communication with a living being. A baseline processor calculates a parameter baseline from an average value of the parameter. Parameter limits specify an allowable range of the parameter. An adaptive threshold processor calculates an adaptive threshold from the parameter baseline and the parameter limits. An alarm generator is responsive to the parameter and the adaptive threshold so as to trigger an alarm indicative of the parameter crossing the adaptive threshold. The adaptive threshold is responsive to the parameter baseline so as to increase in value as the parameter baseline drifts to a higher parameter value and to decrease in value as the parameter baseline drifts to a lower parameter value.

In various embodiments, the baseline processor has a sliding window that identifies a time slice of parameter values. A trend calculator determines a trend from an average of the parameter values in the time slice. A response limiter tracks only the relatively long-term transitions of the trend. A bias calculator deletes the highest parameter values in the time slice or the lowest parameter values in the time slice so as to adjust the baseline to either a lower value or a higher value, respectively. The adaptive threshold becomes less response to baseline drift as the baseline approaches a predefined parameter limit. A first adaptive threshold is responsive to lower parameter limits and a second adaptive threshold is responsive to upper parameter limits. The alarm generator is responsive to both positive and negative transients from the baseline according to the first adaptive threshold and the second adaptive threshold. The first adaptive threshold is increasingly responsive to negative transients and the second adaptive threshold is decreasingly responsive to positive transients as the baseline trends toward lower parameter values.

Another aspect of an adaptive alarm system measures a physiological parameter, establishes a baseline for the parameter, adjusts an alarm threshold according to drift of the baseline and triggers an alarm in response to the parameter measurement crossing the alarm threshold. In various embodiments, the baseline is established by biasing a segment of the parameter, calculating a biased trend from the biased segment and restricting the transient response of the biased trend. The alarm threshold is adjusted by setting a parameter limit and calculating a delta difference between the alarm threshold and the baseline as a linear function of the baseline according to the parameter limit. The delta difference is calculated by decreasing delta as the baseline drifts toward the parameter limit and increasing delta as the baseline drifts away from the parameter limit. A parameter limit is set by selecting a first parameter limit in relation to a delayed alarm and selecting a second parameter limit in relation to an un-delayed alarm. A segment of the parameter is biased by windowing the parameter measurements, removing a lower value portion of the windowed parameter measurements and averaging a remaining portion of the windowed parameter measurements. An upper delta difference between an upper alarm threshold and the baseline is calculated and a lower delta difference between a lower alarm threshold and the baseline is calculated.

A further aspect of an adaptive alarm system has a baseline processor that inputs a parameter and outputs a baseline according to a trend of the parameter. An adaptive threshold processor establishes an alarm threshold at a delta difference from the baseline. An alarm generator triggers an alarm based upon a parameter transient from the baseline crossing the alarm threshold. In various embodiments, a trend calculator outputs a biased trend and the baseline is responsive to the biased trend so as to reduce the size of a transient that triggers the alarm. A response limiter reduces baseline movement due to parameter transients. The adaptive threshold processor establishes a lower alarm threshold below the baseline and an upper alarm threshold above the baseline so that the alarm generator is responsive to both positive and negative transients from the baseline. The baseline processor establishes a lower baseline biased above the parameter trend and an upper baseline biased below the parameter trend. The lower alarm threshold is increasingly responsive to negative transients and the upper alarm threshold is decreasingly responsive to positive transients as the baseline trends toward lower parameter values.

DESCRIPTION OF THE DRAWINGS

FIGS. 1-3 are exemplar graphs illustrating problems and issues associated with physiological parameter measurement systems having fixed threshold alarm schemas;

FIGS. 4A-B are general block diagrams of an adaptive alarm system having lower parameter limits;

FIGS. 5A-B are a graph of a physiological parameter versus delta space and a graph of delta versus baseline, respectively, illustrating the relationship between a baseline, a lower-limit adaptive threshold and a variable difference delta between the baseline and the adaptive threshold;

FIG. 6 is an exemplar graph of a physiological parameter versus time illustrating an adaptive alarm system having a lower-limit adaptive threshold;

FIG. 7 is a graph of oxygen saturation versus time illustrating a baseline for determining an adaptive threshold;

FIG. 8 is a graph of oxygen saturation versus time comparing adaptive-threshold alarm performance with fixed-threshold alarm performance;

FIGS. 9A-B are general block diagrams of an adaptive alarm system having upper parameter limits;

FIGS. 10A-B are a graph of a physiological parameter versus delta space and a graph of delta versus baseline, respectively, illustrating the relationship between a baseline, an upper-limit adaptive threshold and a variable delta difference between the baseline and the adaptive threshold;

FIG. 11 is an exemplar graph of a physiological parameter versus time illustrating an adaptive alarm system having an upper-limit adaptive threshold;

FIGS. 12A-B are general block diagrams of an adaptive alarm system having both lower alarm limits and upper alarm limits;

FIGS. 13A-E are physiological parameter versus delta space graphs illustrating a lower-limit adaptive threshold, an upper-limit adaptive threshold, and a combined lower- and upper-limit adaptive threshold in various delta spaces; and

FIG. 14 is an exemplar graph of a physiological parameter versus time illustrating an adaptive alarm system having both lower and upper alarm limits.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

FIGS. 4A-B illustrate an adaptive alarm system 400 embodiment having lower parameter limits L1 and L2. As shown in FIG. 4A, the adaptive alarm system 400 has parameter 401, first limit (L1) 403, second limit (L2) 405 and maximum parameter value (Max) 406 inputs and generates a corresponding alarm 412 output. The parameter 401 input is generated by a physiological parameter processor, such as a pulse oximeter or an advanced blood parameter processor described above, as examples. The adaptive alarm system 400 has an alarm generator 410, a baseline processor 420, and an adaptive threshold processor 440. The alarm generator 410 has parameter 401 and adaptive threshold (AT) 442 inputs and generates the alarm 412 output accordingly. A baseline processor 420 has the parameter 401 input and generates a parameter baseline (B) 422 output. The baseline processor 420, is described in detail with respect to FIG. 4B, below. An adaptive threshold processor 440 has parameter baseline (B) 422, L1 403, L2 405 and Max 406 inputs and generates the adaptive threshold (AT) 442. The adaptive threshold processor 440 is described in detail with respect to FIGS. 5A-B, below.

As shown in FIG. 4A, in an embodiment L1 403 and L2 405 may correspond to conventional fixed alarm thresholds with and without an alarm time delay, respectively. For an adaptive threshold schema, however, L1 403 and L2 405 do not determine an alarm threshold per se, but are reference levels for determining an adaptive threshold (AT) 442. In an embodiment, L1 403 is an upper limit of the adaptive alarm threshold AT when the baseline is near the maximum parameter value (Max), and L2 405 is a lower limit of the adaptive alarm threshold, as described in detail with respect to FIGS. 5A-B, below. In an exemplar embodiment when the parameter is oxygen saturation, L1 403 is set at or around 90% and L2 405 is set at 5 to 10% below L1, i.e. at 85% to 80% oxygen saturation. Many other L1 and L2 values may be used for an adaptive threshold schema as described herein.

Also shown in FIG. 4A, in an embodiment the alarm 412 output is triggered when the parameter 401 input falls below AT 442 and ends when the parameter 401 input rises above AT 442 or is otherwise cancelled. In an embodiment, the alarm 412 output is triggered after a time delay (TD), which may be fixed or variable. In an embodiment, the time delay (TD) is a function of the adaptive threshold (AT) 442. In an embodiment, the time delay (TD) is zero when the adaptive threshold (AT) is at the second lower limit (L2) 405.

As shown in FIG. 4B, a baseline processor 420 embodiment has a sliding window 450, a bias calculator 460, a trend calculator 470 and a response limiter 480. The sliding window 450 inputs the parameter 401 and outputs a time segment 452 of the parameter 401. In an embodiment, each window incorporates a five minute span of parameter values. The bias calculator 460 advantageously provides an upward shift in the baseline (B) 422 for an additional margin of error over missed true alarms. That is, a baseline 422 is generated that tracks a higher-than-average range of parameter values, effectively raising the adaptive threshold AT slightly above a threshold calculated based upon a true parameter average, as shown and described in detail with respect to FIGS. 7-8, below. In an embodiment, the bias calculator 460 rejects a lower range of parameter values from each time segment 452 from the sliding window so as to generate a biased time segment 462.

Also shown in FIG. 4B, the trend calculator 470 outputs a biased trend 472 of the remaining higher range of parameter values in each biased segment 462. In an embodiment, the biased trend 462 is an average of the values in the biased time segment 462. In other embodiments, the biased trend 462 is a median or mode of the values in the biased time segment 462. The response limiter 480 advantageously limits the extent to which the baseline 422 output tracks the biased trend 472. Accordingly, the baseline 422 tracks only relatively longer-lived transitions of the parameter, but does not track (and hence mask) physiologically significant parameter events, such as oxygen desaturations for a SpO2 parameter to name but one example. In an embodiment, the response limiter 480 has a low pass transfer function. In an embodiment, the response limiter 480 is a slew rate limiter.

FIGS. 5A-B further illustrate an adaptive threshold processor 440 (FIG. 4A) having a baseline (B) 422 input and generating an adaptive threshold (AT) 442 output and a delta (Δ) 444 ancillary output according to parameter limits L1 403, L2 405 and Max 406, as described above. As shown in FIG. 5A, as the baseline (B) 422 decreases (increases) the adaptive threshold (AT) 444 monotonically decreases (increases) between L1 403 and L2 405. Further, as the baseline (B) 422 decreases (increases) the delta (Δ) 444 difference between the baseline (B) 422 and the adaptive threshold (AT) 442 monotonically decreases (increases) between Max−L1 and zero.

As shown in FIG. 5B, the relationship between the delta (Δ) 444 and the baseline (B) 444 may be linear 550 (solid line), non-linear 560 (small-dash lines) or piecewise-linear (large-dash lines), to name a few. In an embodiment, the adaptive threshold processor 440 (FIG. 4A) calculates an adaptive threshold (AT) 442 output in response to the baseline (B) 422 input according to a linear relationship. In a linear embodiment, the adaptive threshold processor 440 (FIG. 4A) calculates the adaptive threshold (AT) 442 according to EQS. 1-2:

Δ = - ( Max - L 1 Max - L 2 ) ( Max - B ) + ( Max - L 1 ) ( 1 ) AT = B - Δ ( 2 )
where Δ=Max−L1 @ B=Max; Δ=0 @ B=L2
and where AT=L1 @ B=Max; AT=L2 @ B=L2, accordingly.

FIG. 6 illustrates the operational characteristics an adaptive alarm system 400 (FIG. 4A) having parameter limits Max 612, L1 614 and L2 616 and an alarm responsive to a baseline (B) 622, 632, 642; an adaptive threshold (AT) 628, 638, 648; and a corresponding Δ 626, 636, 646 according to EQS. 1-2, above. In particular, a physiological parameter 610 is graphed versus time 690 for various time segments t1, t2, t3 692-696. The parameter range (PR) 650 is:
PR=Max−L2   (3)
and the adaptive threshold range (ATR) 660 is:
ATR=L1−L2   (4)

As shown in FIG. 6, during a first time period t1 692, a parameter segment 620 has a baseline (B) 622 at about Max 612. As such, Δ 626=Max−L1 and the adaptive threshold (AT) 628 is at about L1 614. Accordingly, a transient 624 having a size less than Δ 626 does not trigger the alarm 412 (FIG. 4A).

Also shown in FIG. 6, during a second time period t2 694, a parameter segment 630 has a baseline (B) 632 at about L1 614. As such, Δ 636 is less than Max−L1 and the adaptive threshold (AT) 638 is between L1 and L2. Accordingly, a smaller transient 634 will trigger the alarm as compared to a transient 624 in the first time segment.

Further shown in FIG. 6, during a third time period t3 696, a parameter segment 640 has a baseline (B) 642 at about L2 616. As such, Δ 646 is about zero and the adaptive threshold (AT) 648 is at about L2. Accordingly, even a small negative transient will trigger the alarm. As such, the behavior of the alarm threshold AT 628, 638, 648 advantageously adapts to higher or lower baseline values so as to increase or decrease the size of negative transients that trigger or do not trigger the alarm 412 (FIG. 4A).

FIG. 7 is a parameter versus time graph 700 illustrating the characteristics of an adaptive alarm system 400 (FIGS. 4A-B), as described with respect to FIGS. 4-6, above, where the parameter is oxygen saturation (SpO2). The graph 700 has a SpO2 trace 710 and a superimposed baseline trace 720. The graph 700 also delineates tracking periods 730, where the baseline 720 follows the upper portions of SpO2 values, and lagging periods 740, where the baseline 720 does not follow transient SpO2 events. The tracking time periods 730 illustrate that the baseline 720 advantageously tracks at the higher range of SpO2 values 710 during relatively stable (flat) periods, as described above. Lagging time periods 740 illustrate that the baseline 720 is advantageously limited in response to transient desaturation events so that significant desaturations fall below an adaptive threshold (not shown) and trigger an alarm accordingly.

FIG. 8 is a parameter versus time graph 800 illustrating characteristics of an adaptive alarm system 400 (FIGS. 4A-B), as described with respect to FIGS. 4-6, above, where the parameter is oxygen saturation (SpO2). Vertical axis (SpO2) resolution is 1%. The time interval 801 between vertical hash marks is five minutes. The graph 800 has a SpO2 trace 810 and a baseline trace 820. The graph 800 also has a fixed threshold trace 830, a first adaptive threshold (AT) trace 840 and a second AT trace 850. The graph 800 further has a fixed threshold alarm trace 860, a first adaptive threshold alarm trace 870 and a second adaptive threshold alarm trace 880. In this example, L1 is 90% and L2 is 85% for the first AT trace 840 and first AT alarm trace 870. L2 is 80% for a second AT trace 850 and a second AT alarm trace 880. The fixed threshold 830 results in many nuisance alarms 860. By comparison, the adaptive threshold alarm with L2=85% has just one time interval of alarms 872 during a roughly 6% desaturation period (from 92% to 86%). The adaptive threshold alarm with L2=80%, has no alarms during the 1 hour 25 minute monitoring period.

FIGS. 9A-B illustrate an adaptive alarm system 900 embodiment having upper parameter limits U1 and U2. As shown in FIG. 9A, the adaptive alarm system 900 has parameter 901, first limit (U1) 903, second limit (U2) 905 and minimum parameter value (Min) 906 inputs and generates a corresponding alarm 912 output. The parameter 901 input is generated by a physiological parameter processor, such as a pulse oximeter or an advanced blood parameter processor described above, as examples. The adaptive alarm system 900 has an alarm generator 910, a baseline processor 920, and an adaptive threshold processor 940. The alarm generator 910 has parameter 901 and adaptive threshold (AT) 942 inputs and generates the alarm 912 output accordingly. A baseline processor 920 has the parameter 901 input and generates a parameter baseline (B) 922 output. The baseline processor 920, is described in detail with respect to FIG. 9B, below. An adaptive threshold processor 940 has parameter baseline (B) 922, U1 903, U2 905 and Min 906 inputs and generates the adaptive threshold (AT) 942. The adaptive threshold processor 940 is described in detail with respect to FIGS. 10A-B, below.

As shown in FIG. 9A, in an embodiment U1 903 and U2 905 may correspond to conventional fixed alarm thresholds with and without an alarm time delay, respectively. For an adaptive threshold schema, however, U1 903 and U2 905 do not determine an alarm threshold per se, but are reference levels for determining an adaptive threshold (AT) 942. In an embodiment, U1 903 is a lower limit of the adaptive alarm threshold AT when the baseline is near the minimum parameter value (Min), and U2 905 is an upper limit of the adaptive alarm threshold, as described in detail with respect to FIGS. 10A-B, below. In an exemplar embodiment when the parameter is oxygen saturation, U1 903 is set at or around 85% and U2 905 is set at or around 90% oxygen saturation. Many other U1 and U2 values may be used for an adaptive threshold schema as described herein.

Also shown in FIG. 9A, in an embodiment the alarm 912 output is triggered when the parameter 901 input rises above AT 942 and ends when the parameter 901 input falls below AT 942 or is otherwise cancelled. In an embodiment, the alarm 912 output is triggered after a time delay (TD), which may be fixed or variable. In an embodiment, the time delay (TD) is a function of the adaptive threshold (AT) 942. In an embodiment, the time delay (TD) is zero when the adaptive threshold (AT) is at the second upper limit (U2) 905.

As shown in FIG. 9B, a baseline processor 920 embodiment has a sliding window 950, a bias calculator 960, a trend calculator 970 and a response limiter 980. The sliding window 950 inputs the parameter 901 and outputs a time segment 952 of the parameter 901. In an embodiment, each window incorporates a five minute span of parameter values. The bias calculator 960 advantageously provides a downward shift in the baseline (B) 922 for an additional margin of error over missed true alarms. That is, a baseline 922 is generated that tracks a lower-than-average range of parameter values, effectively lowering the adaptive threshold AT slightly below a threshold calculated based upon a true parameter average. In an embodiment, the bias calculator 960 rejects an upper range of parameter values from each time segment 952 from the sliding window so as to generate a biased time segment 962.

Also shown in FIG. 9B, the trend calculator 970 outputs a biased trend 972 of the remaining lower range of parameter values in each biased segment 962. In an embodiment, the biased trend 962 is an average of the values in the biased time segment 962. In other embodiments, the biased trend 962 is a median or mode of the values in the biased time segment 962. The response limiter 980 advantageously limits the extent to which the baseline 922 output tracks the biased trend 972. Accordingly, the baseline 922 tracks only relatively longer-lived transitions of the parameter, but does not track (and hence mask) physiologically significant parameter events, such as oxygen desaturations for a SpO2 parameter to name but one example. In an embodiment, the response limiter 980 has a low pass transfer function. In an embodiment, the response limiter 980 is a slew rate limiter.

FIGS. 10A-B further illustrate an adaptive threshold processor 940 (FIG. 9A) having a baseline (B) 922 input and generating an adaptive threshold (AT) 942 output and a delta (Δ) 944 ancillary output according to parameter limits U1 903, U2 905 and Min 906, as described above. As shown in FIG. 10A, as the baseline (B) 922 decreases (increases) the adaptive threshold (AT) 944 monotonically decreases (increases) between U1 903 and U2 905. Further, as the baseline (B) 922 decreases (increases) the delta (Δ) 944 difference between the baseline (B) 922 and the adaptive threshold (AT) 942 monotonically decreases (increases) between Min−U1 and zero.

As shown in FIG. 10B, the relationship between the delta (Δ) 944 and the baseline (B) 944 may be linear 550 (solid line), non-linear 560 (small-dash lines) or piecewise-linear (large-dash lines), to name a few. In an embodiment, the adaptive threshold processor 940 (FIG. 9A) calculates an adaptive threshold (AT) 942 output in response to the baseline (B) 922 input according to a linear relationship. In a linear embodiment, the adaptive threshold processor 940 (FIG. 9A) calculates the adaptive threshold (AT) 942 according to EQS. 5-6:

Δ = - ( U 1 - Min U 2 - Min ) ( B - Min ) + ( U 1 - Min ) ( 5 ) AT = B + Δ ( 6 )
where Δ=U1−Min @ B=Min; Δ=0 @ B=U2
and where AT=U1 @ B=Min; AT=U2 @ B=U2, accordingly.

FIG. 11 illustrates the operational characteristics an adaptive alarm system 900 (FIG. 9A) having parameter limits Min 1112, U1 1114 and U2 1116 and an alarm responsive to a baseline (B) 1122, 1132, 1142; an adaptive threshold (AT) 1128, 1138, 1148; and a corresponding Δ 1126, 1136, 1146 according to EQS. 5-6, above. In particular, a physiological parameter 1110 is graphed versus time 1190 for various time segments t1, t2, t3 1192-1196. The parameter range (PR) 1150 is:
PR=U2−Min   (7)
and the adaptive threshold range (ATR) 1160 is:
ATR=U2−U1   (8)

As shown in FIG. 11, during a first time period t1 1192, a parameter segment 1120 has a baseline (B) 1122 at about Min 1112. As such, Δ 1126=U1−Min and the adaptive threshold (AT) 1128 is at about U1 1114. Accordingly, a transient 1124 having a size less than Δ 1126 does not trigger the alarm 912 (FIG. 9A).

Also shown in FIG. 11, during a second time period t2 1194, a parameter segment 1130 has a baseline (B) 1132 at about U1 1114. As such, Δ 1136 is less than U1−Min and the adaptive threshold (AT) 1138 is between U1 and U2. Accordingly, a smaller transient 1134 will trigger the alarm as compared to a transient 1124 in the first time segment.

Further shown in FIG. 11, during a third time period t3 1196, a parameter segment 1140 has a baseline (B) 1142 at about U2 1116. As such, Δ 1146 is about zero and the adaptive threshold (AT) 1148 is at about U2. Accordingly, even a small positive transient will trigger the alarm. As such, the behavior of the alarm threshold AT 1128, 1138, 1148 advantageously adapts to higher or lower baseline values so as to increase or decrease the size of positive transients that trigger or do not trigger the alarm 912 (FIG. 9A).

FIGS. 12A-B illustrate an adaptive alarm system 1200 embodiment having lower limits L1, L2 1203, such as described with respect to FIGS. 4A-B above, or upper limits U1, U2 1205 such as described with respect to FIGS. 9A-B above, or both. As shown in FIG. 12A, the adaptive alarm system 1200 has parameter 1201, lower limit 1203 and upper limit 1205 inputs and generates a corresponding alarm 1212 output. The parameter 1201 input is generated by a physiological parameter processor, such as a pulse oximeter or an advanced blood parameter processor described above, as examples. The adaptive alarm system 1200 has an alarm generator 1210, a baseline processor 1220 and an adaptive threshold processor 1240. The alarm generator 1210 has parameter 1201 and adaptive threshold (AT) 1242 inputs and generates the alarm 1212 output accordingly. A baseline processor 1220 has the parameter 1201 input and generates one or more parameter baseline 1222 outputs. The baseline processor 1220, is described in detail with respect to FIG. 12B, below. An adaptive threshold processor 1240 has parameter baseline 1222, lower limit L1, L2 1203 and upper limit U1, U2 1205 inputs and generates lower and upper adaptive threshold ATl, ATu 1242 outputs. The adaptive threshold processor 1240 also generates ancillary upper and lower delta 1244 outputs. The adaptive threshold processor 1240 is described in detail with respect to FIGS. 13A-E, below.

As shown in FIG. 12A, in an embodiment L1, L2 1203 and U1, U2 1205 may correspond to conventional fixed alarm thresholds with an alarm delay (L1, U1) and without an alarm delay (L2, U2). For an adaptive threshold schema, however, these limits 1203, 1205 do not determine an alarm threshold per se, but are reference levels for determining lower and upper adaptive thresholds ATl, ATu 1242.

Also shown in FIG. 12A, in an embodiment the alarm 1212 output is triggered when the parameter 1201 input falls below ATl 1242 and ends when the parameter 1201 input rises above ATl 1242 or the alarm is otherwise cancelled. Further, the alarm 1212 output is triggered when the parameter 1201 input rises above ATu 1242 and ends when the parameter 1201 input falls below ATu 1242 or the alarm is otherwise cancelled. In an embodiment, the alarm 1212 output is triggered after a time delay (TD), which may be fixed or variable. In an embodiment, the time delay (TD) is a function of the adaptive thresholds (ATl, ATu) 1242. In an embodiment, the time delay (TD) is zero when the lower adaptive threshold (ATl) 1242 is at the second lower limit (L2) 1203 or when the upper adaptive alarm threshold ATu 1242 is at the second upper limit (U2) 1205.

As shown in FIG. 12B, a baseline processor 1220 embodiment has a sliding window 1250, an over-bias calculator 1260, an under-bias calculator 1265, trend calculators 1270 and response limiters 1280. The sliding window 1250 inputs the parameter 1201 and outputs a time segment 1252 of the parameter 1201. In an embodiment, each window incorporates a five minute span of parameter 1201 values.

Also shown in FIG. 12B, the over-bias calculator 1260 advantageously provides an upward shift in the lower baseline (Bl) 1282 for an additional margin of error over missed lower true alarms. That is, a lower baseline (Bl) 1282 is generated that tracks a higher-than-average range of parameter values, effectively raising the lower adaptive threshold ATl slightly above a threshold calculated based upon a true parameter average. In an embodiment, the over-bias calculator 1260 rejects a lower range of parameter values from each time segment 1252 of the sliding window 1250 so as to generate an over-biased time segment 1262.

Further shown in FIG. 12B, the under-bias calculator 1265 advantageously provides a downward shift in the upper baseline (Bu) 1287 for an additional margin of error over missed upper true alarms. That is, an upper baseline (Bu) 1287 is generated that tracks a lower-than-average range of parameter values, effectively lowering the upper adaptive threshold ATu slightly below a threshold calculated based upon a true parameter average. In an embodiment, the under-bias calculator 1267 rejects an upper range of parameter values from each time segment 1252 of the sliding window 1250 so as to generate an under-biased time segment 1267.

Additionally shown in FIG. 12B, the trend calculator 1270 outputs an over-biased trend 1272 of the remaining higher range of parameter values in each over-biased segment 1262. Further, the trend calculator 1270 outputs an under-biased trend 1277 of the remaining lower range of parameter values in each under-biased segment 1267. In an embodiment, the biased trends 1272, 1277 are each an average of the values in the corresponding biased time segments 1262, 1267. In other embodiments, the biased trends 1272, 1277 are each a median or mode of the values in the corresponding biased time segments 1262, 1267. The response limiter 1280 advantageously limits the extent to which the baseline 1222 outputs track the biased trends 1272, 1277. Accordingly, the baseline 1222 outputs track only relatively longer-lived transitions of the parameter 1201, but do not track (and hence mask) physiologically significant parameter events. In an embodiment, the response limiter 1280 has a low pass transfer function. In an embodiment, the response limiter 1280 is a slew rate limiter.

FIGS. 13A-E illustrate parameter (P) operating ranges and ideal ranges in view of both lower and upper parameter limits. As shown in FIG. 13A, as the baseline (Bl) 1317 decreases (increases) the adaptive threshold (ATl) 1318 monotonically decreases (increases) between L1 and L2. Further, as the baseline (Bl) 1317 decreases (increases) the delta (Δl) 1319 difference between the baseline (Bl) 1317 and the adaptive threshold (ATl) 1318 monotonically decreases (increases) between Max−L1 and 0.

As shown in FIG. 13B, as the baseline (Bu) 1327 increases (decreases) the adaptive threshold (ATu) 1328 monotonically increases (decreases) between U1 and U2. Further, as the baseline (Bu) 1327 increases (decreases) the delta (Δu) 1329 difference between the adaptive threshold (ATu) 1328 and the baseline (Bu) 1327 monotonically decreases (increases) between Min−U1 and 0.

As shown in FIG. 13C, combining FIGS. 13A-B, the parameter (P) operating range is bounded by the overlapping regions of 13A and 13B 1330 having an upper bound of U2 and a lower bound of L2. In particular, L1, L2 are the upper and lower limits of the lower adaptive alarm threshold ATl; and U2, U1 are the upper and lower limits of the upper adaptive alarm threshold ATu.

FIG. 13D illustrates parameter (P) versus the overlapping independent delta domains Fu, Fl for upper and lower baselines Bu, Bl; adaptive thresholds ATu, ATl and deltas Δu, Δl, based upon FIGS. 13A-C. FIG. 13E illustrates parameter (P) versus the overlapping independent delta domains Fu, Fl (reversed); for upper and lower baselines Bu, Bl; adaptive thresholds ATu, ATl and deltas Δu, Δl,

As shown in FIG. 13E, the equations for bi-lateral adaptive thresholds are:

Δ u = - ( U 1 - L 2 U 2 - L 2 ) ( B - L 2 ) + ( U 1 - L 2 ) ( 9 ) AT u = B + Δ u ( 10 )
where Δu=U12 @ B=L2; and Δu=0 @ B=U2; and
where ATu=U1 @ B=L2; and ATu=U2 @ B=U2.
Further:

Δ l = ( U 2 - L 1 U 2 - L 2 ) ( B - L 2 ) ( 11 ) AT l = B - Δ l ( 12 )
where Δl=U2−L1 @ B=U2; and Δl=0 @ B=L2; and
where ATl=L1 @ B=U2; ATl=L2 @ B=L2.

Although shown as a linear relationship, in general:
Δl=f1(B);Δu=f2(B)
That is, Δl and Δu can each be a linear function of B, a non-linear function of B or a piecewise linear function of B, to name a few, in a manner similar to that described with respect to FIGS. 5B and 10B, above.

FIGS. 14A-B illustrate the operational characteristics an adaptive alarm system 1200 (FIGS. 12A-B) having upper limits U1, U2 1412, 1414 and lower limits L1, L2 1422, 1424. An alarm 1212 (FIG. 12A) output is responsive to a baseline (B) 1432, 1442, 1452, 1462; an upper delta (Δu) 1437, 1447, 1457, 1467; and a corresponding upper adaptive threshold (ATu) 1439, 1449, 1459, 1469, according to EQS. 9-10, above. Further, the alarm 1212 (FIG. 12A) output is responsive to a lower delta (Δl) 1436, 1446, 1456, 1466 and a corresponding lower adaptive threshold (ATl) 1438, 1448, 1458, 1468, according to EQS. 11-12, above.

As shown in FIGS. 14A-B, a physiological parameter 1410 is graphed versus time 1490 for various time segments t1, t2, t3, t4 1492-1498. The parameter range (PR) 1480 is:
PR=U2−L2   (13)

the lower adaptive threshold ATl range is:
ATRl=L1−L2   (14)
the upper adaptive threshold ATU range is:
ATRl=U2−U1   (15)

As shown in FIG. 14A, during a first time period t1 1492, a parameter segment 1430 has a baseline (B) 1432 at about U2 1414. As such, Δl 1436=U2−L1; Δu 1437=0; ATl 1438=L1; ATu 1439=U2. Accordingly, a negative transient 1434 having a size less than U2−L1 does not trigger an alarm.

Also shown in FIG. 14A, during a second time period t2 1494, a parameter segment 1440 has a baseline (B) 1442 less than U2. As such, Δl 1446 is less than U1−L1 and the adaptive threshold (ATu) 1447 is between U1 and U2. Accordingly, a smaller negative transient 1444 will trigger the alarm as compared to the negative transient 1434 in the first time segment 1430.

Further shown in FIG. 14A, during a third time period t3 1496, a parameter segment 1450 has a baseline (B) 1452 less than U1 1412. As such, a smaller negative transient 1454 will trigger the alarm as compared to the negative transient 1444 in the second time segment 1440. However, a larger positive transient 1455 is needed to trigger the alarm as compared to the positive transient 1445 in the second time segment 1440.

Additionally shown in FIG. 14A, during a fourth time period t4 1460, a parameter segment 1460 has a baseline (B) 1462 at about L2 1424. As such, Δl 1466=0; Δu 1467=U1−L2; ATl 1468=L2; ATu 1469=U1. Accordingly, a positive transient 1465 having a size less than U1−L2 does not trigger an alarm.

An adaptive alarm system has been disclosed in detail in connection with various embodiments. These embodiments are disclosed by way of examples only and are not to limit the scope of the claims that follow. One of ordinary skill in the art will appreciate many variations and modifications.

Claims

1. A system for reducing electronic alarms in a medical patient monitoring system, the system comprising:

an optical sensor configured to transmit optical radiation into a tissue site of a patient and detect attenuated optical radiation indicative of at least one physiological parameter of a patient; and
one or more hardware processors in electronic communication with the optical sensor, the one or more hardware processors configured to: measure oxygen saturation values of a patient over a first period of time; determine if at least one oxygen saturation value obtained over the first period of time exceeds a first alarm threshold; determine whether a first alarm should be triggered based on the determination that the at least one oxygen saturation value obtained over the first period of time exceeds the first alarm threshold; determine a second alarm threshold to be applied during a second period of time subsequent to the first period of time, the second alarm threshold replacing the first alarm threshold, the second alarm threshold being determined by: comparing at least a first oxygen saturation value obtained during the first time period with a lower limit associated with oxygen saturation; and computing a second alarm threshold based on the comparison where the second alarm threshold is computed to be at a value less than the at least first oxygen saturation value and greater than the lower limit and at an offset from the first oxygen saturation value, wherein the offset is configured to diminish as a difference between the at least first oxygen saturation value and the lower limit diminishes; measure oxygen saturation values of a patient over the second period of time to determine at least a second oxygen saturation value; and determine whether a second alarm should be triggered by determining if at least one oxygen saturation value obtained during the second period of time exceeds the second alarm threshold and triggering an alarm if it is determined the second alarm should be triggered.

2. The system of claim 1, wherein the one or more hardware processors are configured to calculate a first baseline measurement from the measured oxygen saturation values over the first period of time and wherein the at least one oxygen saturation value obtained during the first period of time corresponds to the first baseline measurement.

3. The system of claim 2, wherein the one or more hardware processors are configured to calculate a second baseline measurement from the measured oxygen saturation values over the second period of time and wherein the at least one oxygen saturation value obtained during the second period of time corresponds to the second baseline measurement.

4. The system of claim 1, wherein the lower limit is predefined and corresponds to a minimum parameter value for oxygen saturation.

5. The system of claim 1, wherein the one or more hardware processors are further configured to wait for a time delay prior to the triggering of the second alarm, and wherein the time delay is a function of the second alarm threshold.

6. The system of claim 5, wherein the time delay decreases as the difference between the at least first oxygen saturation value and the lower limit diminishes.

7. The system of claim 1, wherein the first alarm threshold is predetermined.

8. A system for reducing electronic alarms in a medical patient monitoring system including a pulse oximeter in communication with an optical sensor, the system comprising one or more hardware processors configured to:

measure oxygen saturation values of a patient over a first period of time;
determine if at least one oxygen saturation value obtained over the first period of time exceeds a first alarm threshold;
determine whether a first alarm should be triggered based on the determination that the at least one oxygen saturation value obtained over the first period of time exceeds the first alarm threshold;
compare at least a first oxygen saturation value obtained during the first time period with a lower limit associated with oxygen saturation;
compute a second alarm threshold based on the comparison;
determine a time delay based on the computed second alarm threshold, wherein the time delay approaches zero as the first oxygen saturation value approaches the lower limit;
measure oxygen saturation values of a patient over the second period of time to determine at least a second oxygen saturation value; and
determine whether a second alarm should be triggered by determining if at least one oxygen saturation value obtained during the second period of time exceeds the second alarm threshold for the time delay and triggering an alarm if it is determined the second alarm should be triggered.

9. The system of claim 8, wherein the first alarm threshold is predetermined.

10. The system of claim 8, wherein the lower limit is predefined and corresponds to a minimum parameter value for oxygen saturation.

11. The system of claim 8, where the second alarm threshold is computed to be at a value less than the at least first oxygen saturation value and greater than the lower limit and at an offset from the first oxygen saturation value, wherein the offset is configured to diminish as a difference between the at least first oxygen saturation value and the lower limit diminishes.

12. An electronic method for reducing electronic alarms in a medical patient monitoring system, the electronic method comprising:

measuring oxygen saturation values of a patient over a first period of time;
determining if at least one oxygen saturation value determined over the first period of time exceeds a first alarm threshold;
determining whether a first alarm should be triggered based on the determination that at least one oxygen saturation value obtained during the first period of time exceeds the first alarm threshold;
comparing at least a first oxygen saturation value obtained during the first time period with a lower limit associated with oxygen saturation;
computing the second alarm threshold based on the comparison where the second alarm threshold is computed to be at a value less than the at least first oxygen saturation value and greater than the lower limit and at an offset from the first oxygen saturation value, wherein the offset is configured to diminish as a difference between the at least first oxygen saturation value and the lower limit diminishes and wherein the second alarm threshold is configured to be applied during a second period of time subsequent to the first period of time, the second alarm threshold replacing the first alarm threshold; measuring oxygen saturation values of a patient over the second period of time to determine at least a second oxygen saturation value; and determining whether a second alarm should be triggered by determining if at least one oxygen saturation value obtained during the second period of time exceeds the second alarm threshold and triggering an alarm if it is determined the second alarm should be triggered.

13. The electronic method of claim 12, wherein the one or more hardware processors are configured to calculate a first baseline measurement from the measured oxygen saturation values over the first period of time and wherein the at least one oxygen saturation value obtained during the first period of time corresponds to the first baseline measurement.

14. The electronic method of claim 13, wherein the one or more hardware processors are configured to calculate a second baseline measurement from the measured oxygen saturation values over the second period of time and wherein the at least one oxygen saturation value obtained during the second period of time corresponds to the second baseline measurement.

15. The electronic method of claim 12, wherein the lower limit is predefined and corresponds to a minimum parameter value for oxygen saturation.

16. The electronic method of claim 12, wherein the one or more hardware processors are further configured to wait for a time delay prior to the triggering of the second alarm, and wherein the time delay is a function of the second alarm threshold.

17. The electronic method of claim 16, wherein the time delay decreases as the difference between the at least first oxygen saturation value and the lower limit diminishes.

18. The electronic method of claim 12, wherein the first alarm threshold is predetermined.

19. A non-transitory physical computer storage comprising computer-executable instructions stored thereon that, when executed by one or more processors, are configured to implement a process comprising:

transmitting optical radiation into a tissue site of a patient and detecting attenuated optical radiation indicative of an oxygen saturation of a patient;
defining a limit that corresponds to a reference level for a determination of an alarm threshold; and
using an alarm threshold in determining whether to activate an alarm, the alarm threshold being at a value less than a prior oxygen saturation of the patient by a difference, wherein the difference diminishes based on the prior oxygen saturation of the patient approaching the limit.

20. The non-transitory physical computer storage of claim 19, wherein the difference diminishes in response to a decrease in the patient's oxygen saturation until it reaches zero.

21. The non-transitory physical computer storage of claim 19, wherein the diminishment is proportional to the difference.

22. The non-transitory physical computer storage of claim 19, wherein the diminishment is a piecewise function of discrete diminishment steps.

23. The non-transitory physical computer storage of claim 19, wherein the process further comprises automatically determining the alarm threshold.

24. The non-transitory physical computer storage of claim 19, wherein the limit is set at 85% oxygen saturation.

25. The non-transitory physical computer storage of claim 19, wherein the limit is set at 80% oxygen saturation.

26. The non-transitory physical computer storage of claim 19, wherein the limit is set between 80% to 85% oxygen saturation.

27. The non-transitory physical computer storage of claim 19, wherein the limit is predefined.

28. The non-transitory physical computer storage of claim 19, wherein the process further comprises waiting for a time delay prior to activating the alarm, wherein the time delay is based on the alarm threshold.

29. The non-transitory physical computer storage of claim 28, wherein the time delay decreases based on the prior oxygen saturation of the patient approaching the limit.

Referenced Cited
U.S. Patent Documents
3608545 September 1971 Novak et al.
4338950 July 13, 1982 Barlow, Jr. et al.
4425921 January 17, 1984 Fujisaki et al.
4450843 May 29, 1984 Barney et al.
4557545 December 10, 1985 Ohtsuki et al.
4639718 January 27, 1987 Gasper
4653498 March 31, 1987 New et al.
4807639 February 28, 1989 Shimizu et al.
4883055 November 28, 1989 Merrick
4889132 December 26, 1989 Hutcheson et al.
4896676 January 30, 1990 Sasaki
4960128 October 2, 1990 Gordon et al.
4964408 October 23, 1990 Hink et al.
4975684 December 4, 1990 Guttinger et al.
5041187 August 20, 1991 Hink et al.
5069213 December 3, 1991 Polczynski
5111817 May 12, 1992 Clark et al.
5163438 November 17, 1992 Gordon et al.
5226417 July 13, 1993 Swedlow et al.
5253645 October 19, 1993 Friedman et al.
5253646 October 19, 1993 Delpy et al.
5285782 February 15, 1994 Prosser
5319355 June 7, 1994 Russek
5319363 June 7, 1994 Welch
5337744 August 16, 1994 Branigan
5341805 August 30, 1994 Stavridi et al.
D353195 December 6, 1994 Savage et al.
D353196 December 6, 1994 Savage et al.
5377676 January 3, 1995 Vari et al.
D359546 June 20, 1995 Savage et al.
5431170 July 11, 1995 Mathews
5436499 July 25, 1995 Namavar et al.
D361840 August 29, 1995 Savage et al.
D362063 September 5, 1995 Savage et al.
5452717 September 26, 1995 Branigan et al.
D363120 October 10, 1995 Savage et al.
5456252 October 10, 1995 Vari et al.
5464012 November 7, 1995 Falcone
5479934 January 2, 1996 Imran
5482036 January 9, 1996 Diab et al.
5490505 February 13, 1996 Diab et al.
5494043 February 27, 1996 O'Sullivan et al.
5533511 July 9, 1996 Kaspari et al.
5534851 July 9, 1996 Russek
5539706 July 23, 1996 Takenaka et al.
5561275 October 1, 1996 Savage et al.
5562002 October 8, 1996 Lalin
5590649 January 7, 1997 Caro et al.
5602924 February 11, 1997 Durand et al.
5615684 April 1, 1997 Hagel et al.
5632272 May 27, 1997 Diab et al.
5637002 June 10, 1997 Buck et al.
5638816 June 17, 1997 Kiani-Azarbayjany et al.
5638818 June 17, 1997 Diab et al.
5645440 July 8, 1997 Tobler et al.
5671914 September 30, 1997 Kalkhoran et al.
5685299 November 11, 1997 Diab et al.
D390192 February 3, 1998 Ono
D391551 March 3, 1998 Ono
5726440 March 10, 1998 Kalkhoran et al.
D393830 April 28, 1998 Tobler et al.
5743262 April 28, 1998 Lepper, Jr. et al.
5747806 May 5, 1998 Khalil et al.
5750994 May 12, 1998 Schlager
5758644 June 2, 1998 Diab et al.
5760910 June 2, 1998 Lepper, Jr. et al.
5769785 June 23, 1998 Diab et al.
5782757 July 21, 1998 Diab et al.
5785659 July 28, 1998 Caro et al.
5791347 August 11, 1998 Flaherty et al.
5793413 August 11, 1998 Hylton et al.
5810734 September 22, 1998 Caro et al.
5823950 October 20, 1998 Diab et al.
5830131 November 3, 1998 Caro et al.
5833618 November 10, 1998 Caro et al.
5860919 January 19, 1999 Kiani-Azarbayjany et al.
5865736 February 2, 1999 Baker, Jr. et al.
5876348 March 2, 1999 Sugo et al.
5890929 April 6, 1999 Mills et al.
5904654 May 18, 1999 Wohltmann et al.
5919134 July 6, 1999 Diab
5919141 July 6, 1999 Money et al.
5920263 July 6, 1999 Huttenhoff et al.
5934925 August 10, 1999 Tobler et al.
5940182 August 17, 1999 Lepper, Jr. et al.
5987343 November 16, 1999 Kinast
5995855 November 30, 1999 Kiani et al.
5997343 December 7, 1999 Mills et al.
6002952 December 14, 1999 Diab et al.
6005658 December 21, 1999 Kaluza et al.
6010937 January 4, 2000 Karam et al.
6011986 January 4, 2000 Diab et al.
6027452 February 22, 2000 Flaherty et al.
6036642 March 14, 2000 Diab et al.
6040578 March 21, 2000 Malin et al.
6045509 April 4, 2000 Caro et al.
6050951 April 18, 2000 Friedman et al.
6066204 May 23, 2000 Haven
6067462 May 23, 2000 Diab et al.
6081735 June 27, 2000 Diab et al.
6088607 July 11, 2000 Diab et al.
6110522 August 29, 2000 Lepper, Jr. et al.
6115673 September 5, 2000 Malin et al.
6124597 September 26, 2000 Shehada
6128521 October 3, 2000 Marro et al.
6129675 October 10, 2000 Jay
6144868 November 7, 2000 Parker
6151516 November 21, 2000 Kiani-Azarbayjany et al.
6152754 November 28, 2000 Gerhardt et al.
6157850 December 5, 2000 Diab et al.
6165005 December 26, 2000 Mills et al.
6166633 December 26, 2000 Wang et al.
6184521 February 6, 2001 Coffin, IV et al.
6190325 February 20, 2001 Narimatsu
6206830 March 27, 2001 Diab et al.
6229856 May 8, 2001 Diab et al.
6232609 May 15, 2001 Snyder et al.
6236872 May 22, 2001 Diab et al.
6241661 June 5, 2001 Schluess et al.
6241683 June 5, 2001 Macklem et al.
6241684 June 5, 2001 Amano et al.
6253097 June 26, 2001 Aronow et al.
6255708 July 3, 2001 Sudharsanan et al.
6256523 July 3, 2001 Diab et al.
6263222 July 17, 2001 Diab et al.
6278522 August 21, 2001 Lepper, Jr. et al.
6280213 August 28, 2001 Tobler et al.
6280381 August 28, 2001 Malin et al.
6285896 September 4, 2001 Tobler et al.
6301493 October 9, 2001 Marro et al.
6308089 October 23, 2001 von der Ruhr et al.
6317627 November 13, 2001 Ennen et al.
6321100 November 20, 2001 Parker
6325761 December 4, 2001 Jay
6334065 December 25, 2001 Al-Ali et al.
6343224 January 29, 2002 Parker
6349228 February 19, 2002 Kiani et al.
6360114 March 19, 2002 Diab et al.
6368283 April 9, 2002 Xu et al.
6371921 April 16, 2002 Caro et al.
6377829 April 23, 2002 Al-Ali
6388240 May 14, 2002 Schulz et al.
6397091 May 28, 2002 Diab et al.
6411373 June 25, 2002 Garside et al.
6415167 July 2, 2002 Blank et al.
6430437 August 6, 2002 Marro
6430525 August 6, 2002 Weber et al.
6463311 October 8, 2002 Diab
6470199 October 22, 2002 Kopotic et al.
6487429 November 26, 2002 Hockersmith et al.
6501975 December 31, 2002 Diab et al.
6505059 January 7, 2003 Kollias et al.
6510344 January 21, 2003 Halpern
6515273 February 4, 2003 Al-Ali
6519487 February 11, 2003 Parker
6525386 February 25, 2003 Mills et al.
6526300 February 25, 2003 Kiani et al.
6534012 March 18, 2003 Hazen et al.
6541756 April 1, 2003 Schulz et al.
6542764 April 1, 2003 Al-Ali et al.
6553242 April 22, 2003 Sarussi
6580086 June 17, 2003 Schulz et al.
6584336 June 24, 2003 Ali et al.
6587196 July 1, 2003 Stippick et al.
6587199 July 1, 2003 Luu
6595316 July 22, 2003 Cybulski et al.
6597932 July 22, 2003 Tian et al.
6597933 July 22, 2003 Kiani et al.
6606511 August 12, 2003 Ali et al.
6632181 October 14, 2003 Flaherty et al.
6635559 October 21, 2003 Greenwald et al.
6639668 October 28, 2003 Trepagnier
6640116 October 28, 2003 Diab
6640117 October 28, 2003 Makarewicz et al.
6643530 November 4, 2003 Diab et al.
6645155 November 11, 2003 Inukai et al.
6650917 November 18, 2003 Diab et al.
6654624 November 25, 2003 Diab et al.
6658276 December 2, 2003 Kiani et al.
6661161 December 9, 2003 Lanzo et al.
6671531 December 30, 2003 Al-Ali et al.
6678543 January 13, 2004 Diab et al.
6684090 January 27, 2004 Ali et al.
6684091 January 27, 2004 Parker
6697656 February 24, 2004 Al-Ali
6697657 February 24, 2004 Shehada et al.
6697658 February 24, 2004 Al-Ali
RE38476 March 30, 2004 Diab et al.
6699194 March 2, 2004 Diab et al.
6714804 March 30, 2004 Al-Ali et al.
RE38492 April 6, 2004 Diab et al.
6721582 April 13, 2004 Trepagnier et al.
6721585 April 13, 2004 Parker
6725075 April 20, 2004 Al-Ali
6728560 April 27, 2004 Kollias et al.
6735459 May 11, 2004 Parker
6738652 May 18, 2004 Mattu et al.
6745060 June 1, 2004 Diab et al.
6754516 June 22, 2004 Mannheimer
6755689 June 29, 2004 Zhang et al.
6760607 July 6, 2004 Al-Ali
6770028 August 3, 2004 Ali et al.
6771994 August 3, 2004 Kiani et al.
6788965 September 7, 2004 Ruchti et al.
6792300 September 14, 2004 Diab et al.
6813511 November 2, 2004 Diab et al.
6816241 November 9, 2004 Grubisic
6816266 November 9, 2004 Varshneya et al.
6816741 November 9, 2004 Diab
6822564 November 23, 2004 Al-Ali
6826419 November 30, 2004 Diab et al.
6830711 December 14, 2004 Mills et al.
6840904 January 11, 2005 Goldberg
6850787 February 1, 2005 Weber et al.
6850788 February 1, 2005 Al-Ali
6852083 February 8, 2005 Caro et al.
6861639 March 1, 2005 Al-Ali
6876931 April 5, 2005 Lorenz et al.
6897788 May 24, 2005 Khair et al.
6898452 May 24, 2005 Al-Ali et al.
6920345 July 19, 2005 Al-Ali et al.
6931268 August 16, 2005 Kiani-Azarbayjany et al.
6934570 August 23, 2005 Kiani et al.
6939305 September 6, 2005 Flaherty et al.
6943348 September 13, 2005 Coffin, IV
6950687 September 27, 2005 Al-Ali
6956649 October 18, 2005 Acosta et al.
6961598 November 1, 2005 Diab
6970792 November 29, 2005 Diab
6979812 December 27, 2005 Al-Ali
6985764 January 10, 2006 Mason et al.
6990364 January 24, 2006 Ruchti et al.
6993371 January 31, 2006 Kiani et al.
6996427 February 7, 2006 Ali et al.
6998247 February 14, 2006 Monfre et al.
6999904 February 14, 2006 Weber et al.
7003338 February 21, 2006 Weber et al.
7003339 February 21, 2006 Diab et al.
7015451 March 21, 2006 Dalke et al.
7024233 April 4, 2006 Ali et al.
7027849 April 11, 2006 Al-Ali
7030749 April 18, 2006 Al-Ali
7039449 May 2, 2006 Al-Ali
7041060 May 9, 2006 Flaherty et al.
7044918 May 16, 2006 Diab
7067893 June 27, 2006 Mills et al.
7079035 July 18, 2006 Bock et al.
D526719 August 15, 2006 Richie, Jr. et al.
7096052 August 22, 2006 Mason et al.
7096054 August 22, 2006 Abdul-Hafiz et al.
D529616 October 3, 2006 Deros et al.
7123950 October 17, 2006 Mannheimer
7132641 November 7, 2006 Schulz et al.
7133710 November 7, 2006 Acosta et al.
7142901 November 28, 2006 Kiani et al.
7149561 December 12, 2006 Diab
7186966 March 6, 2007 Al-Ali
7190261 March 13, 2007 Al-Ali
7215984 May 8, 2007 Diab
7215986 May 8, 2007 Diab
7221971 May 22, 2007 Diab
7225006 May 29, 2007 Al-Ali et al.
7225007 May 29, 2007 Al-Ali
RE39672 June 5, 2007 Shehada et al.
7239905 July 3, 2007 Kiani-Azarbayjany et al.
7245953 July 17, 2007 Parker
7254429 August 7, 2007 Schurman et al.
7254431 August 7, 2007 Al-Ali et al.
7254433 August 7, 2007 Diab et al.
7254434 August 7, 2007 Schulz et al.
7272425 September 18, 2007 Al-Ali
7274955 September 25, 2007 Kiani et al.
D554263 October 30, 2007 Al-Ali
7280858 October 9, 2007 Al-Ali et al.
7289835 October 30, 2007 Mansfield et al.
7292883 November 6, 2007 De Felice et al.
7295866 November 13, 2007 Al-Ali
7328053 February 5, 2008 Diab et al.
7332784 February 19, 2008 Mills et al.
7340287 March 4, 2008 Mason et al.
7341559 March 11, 2008 Schulz et al.
7343186 March 11, 2008 Lamego et al.
D566282 April 8, 2008 Al-Ali et al.
7355512 April 8, 2008 Al-Ali
7356365 April 8, 2008 Schurman
7371981 May 13, 2008 Abdul-Hafiz
7373193 May 13, 2008 Al-Ali et al.
7373194 May 13, 2008 Weber et al.
7376453 May 20, 2008 Diab et al.
7377794 May 27, 2008 Al-Ali et al.
7377899 May 27, 2008 Weber et al.
7383070 June 3, 2008 Diab et al.
7395158 July 1, 2008 Monfre et al.
7399277 July 15, 2008 Saidara et al.
7415297 August 19, 2008 Al-Ali et al.
7428432 September 23, 2008 Ali et al.
7438683 October 21, 2008 Al-Ali et al.
7440787 October 21, 2008 Diab
7454240 November 18, 2008 Diab et al.
7467002 December 16, 2008 Weber et al.
7469157 December 23, 2008 Diab et al.
7471969 December 30, 2008 Diab et al.
7471971 December 30, 2008 Diab et al.
7483729 January 27, 2009 Al-Ali et al.
7483730 January 27, 2009 Diab et al.
7489958 February 10, 2009 Diab et al.
7496391 February 24, 2009 Diab et al.
7496393 February 24, 2009 Diab et al.
D587657 March 3, 2009 Al-Ali et al.
7499741 March 3, 2009 Diab et al.
7499835 March 3, 2009 Weber et al.
7500950 March 10, 2009 Al-Ali et al.
7509154 March 24, 2009 Diab et al.
7509494 March 24, 2009 Al-Ali
7510849 March 31, 2009 Schurman et al.
7514725 April 7, 2009 Wojtczuk et al.
7519406 April 14, 2009 Blank et al.
7526328 April 28, 2009 Diab et al.
D592507 May 19, 2009 Wachman et al.
7530942 May 12, 2009 Diab
7530949 May 12, 2009 Al Ali et al.
7530955 May 12, 2009 Diab et al.
7563110 July 21, 2009 Al-Ali et al.
7593230 September 22, 2009 Abul-Haj et al.
7596398 September 29, 2009 Al-Ali et al.
7606608 October 20, 2009 Blank et al.
7618375 November 17, 2009 Flaherty
7620674 November 17, 2009 Ruchti et al.
D606659 December 22, 2009 Kiani et al.
7629039 December 8, 2009 Eckerbom et al.
7640140 December 29, 2009 Ruchti et al.
7647083 January 12, 2010 Al-Ali et al.
D609193 February 2, 2010 Al-Ali et al.
D614305 April 20, 2010 Al-Ali et al.
7697966 April 13, 2010 Monfre et al.
7698105 April 13, 2010 Ruchti et al.
RE41317 May 4, 2010 Parker
RE41333 May 11, 2010 Blank et al.
7729733 June 1, 2010 Al-Ali et al.
7734320 June 8, 2010 Al-Ali
7761127 July 20, 2010 Al-Ali et al.
7761128 July 20, 2010 Al-Ali et al.
7764982 July 27, 2010 Dalke et al.
D621516 August 10, 2010 Kiani et al.
7769436 August 3, 2010 Boileau et al.
7791155 September 7, 2010 Diab
7801581 September 21, 2010 Diab
7822452 October 26, 2010 Schurman et al.
RE41912 November 2, 2010 Parker
7844313 November 30, 2010 Kiani et al.
7844314 November 30, 2010 Al-Ali
7844315 November 30, 2010 Al-Ali
7865222 January 4, 2011 Weber et al.
7873497 January 18, 2011 Weber et al.
7880606 February 1, 2011 Al-Ali
7880626 February 1, 2011 Al-Ali et al.
7891355 February 22, 2011 Al-Ali et al.
7894868 February 22, 2011 Al-Ali et al.
7899507 March 1, 2011 Al-Ali et al.
7899518 March 1, 2011 Trepagnier et al.
7904132 March 8, 2011 Weber et al.
7909772 March 22, 2011 Popov et al.
7910875 March 22, 2011 Al-Ali
7919713 April 5, 2011 Al-Ali et al.
7937128 May 3, 2011 Al-Ali
7937129 May 3, 2011 Mason et al.
7937130 May 3, 2011 Diab et al.
7941199 May 10, 2011 Kiani
7951086 May 31, 2011 Flaherty et al.
7957780 June 7, 2011 Lamego et al.
7962188 June 14, 2011 Kiani et al.
7962190 June 14, 2011 Diab et al.
7976472 July 12, 2011 Kiani
7988637 August 2, 2011 Diab
7990382 August 2, 2011 Kiani
7991446 August 2, 2011 Ali et al.
8000761 August 16, 2011 Al-Ali
8008088 August 30, 2011 Bellott et al.
RE42753 September 27, 2011 Kiani-Azarbayjany et al.
8019400 September 13, 2011 Diab et al.
8028701 October 4, 2011 Al-Ali et al.
8029765 October 4, 2011 Bellott et al.
8036727 October 11, 2011 Schurman et al.
8036728 October 11, 2011 Diab et al.
8046040 October 25, 2011 Ali et al.
8046041 October 25, 2011 Diab et al.
8046042 October 25, 2011 Diab et al.
8048040 November 1, 2011 Kiani
8050728 November 1, 2011 Al-Ali et al.
RE43169 February 7, 2012 Parker
8118620 February 21, 2012 Al-Ali et al.
8126528 February 28, 2012 Diab et al.
8128572 March 6, 2012 Diab et al.
8130105 March 6, 2012 Al-Ali et al.
8145287 March 27, 2012 Diab et al.
8150487 April 3, 2012 Diab et al.
8175672 May 8, 2012 Parker
8180420 May 15, 2012 Diab et al.
8182443 May 22, 2012 Kiani
8185180 May 22, 2012 Diab et al.
8190223 May 29, 2012 Al-Ali et al.
8190227 May 29, 2012 Diab et al.
8203438 June 19, 2012 Kiani et al.
8203704 June 19, 2012 Merritt et al.
8204566 June 19, 2012 Schurman et al.
8214043 July 3, 2012 Matos
8219172 July 10, 2012 Schurman et al.
8224411 July 17, 2012 Al-Ali et al.
8228181 July 24, 2012 Al-Ali
8229532 July 24, 2012 Davis
8229533 July 24, 2012 Diab et al.
8233955 July 31, 2012 Al-Ali et al.
8244325 August 14, 2012 Al-Ali et al.
8255026 August 28, 2012 Al-Ali
8255027 August 28, 2012 Al-Ali et al.
8255028 August 28, 2012 Al-Ali et al.
8260577 September 4, 2012 Weber et al.
8265723 September 11, 2012 McHale et al.
8274360 September 25, 2012 Sampath et al.
8280473 October 2, 2012 Al-Ali
8301217 October 30, 2012 Al-Ali et al.
8306596 November 6, 2012 Schurman et al.
8310336 November 13, 2012 Muhsin et al.
8315683 November 20, 2012 Al-Ali et al.
RE43860 December 11, 2012 Parker
8337403 December 25, 2012 Al-Ali et al.
8346330 January 1, 2013 Lamego
8353842 January 15, 2013 Al-Ali et al.
8355766 January 15, 2013 MacNeish, III et al.
8359080 January 22, 2013 Diab et al.
8364223 January 29, 2013 Al-Ali et al.
8364226 January 29, 2013 Diab et al.
8374665 February 12, 2013 Lamego
8385995 February 26, 2013 Al-Ali et al.
8385996 February 26, 2013 Smith et al.
8388353 March 5, 2013 Kiani et al.
8399822 March 19, 2013 Al-Ali
8401602 March 19, 2013 Kiani
8401607 March 19, 2013 Mannheimer
8405608 March 26, 2013 Al-Ali et al.
8414499 April 9, 2013 Al-Ali et al.
8418524 April 16, 2013 Al-Ali
8423106 April 16, 2013 Lamego et al.
8428967 April 23, 2013 Olsen et al.
8430817 April 30, 2013 Al-Ali et al.
8437825 May 7, 2013 Dalvi et al.
8455290 June 4, 2013 Siskavich
8457703 June 4, 2013 Al-Ali
8457707 June 4, 2013 Kiani
8463349 June 11, 2013 Diab et al.
8466286 June 18, 2013 Bellott et al.
8471713 June 25, 2013 Poeze et al.
8473020 June 25, 2013 Kiani et al.
8483787 July 9, 2013 Al-Ali et al.
8489364 July 16, 2013 Weber et al.
8498684 July 30, 2013 Weber et al.
8504128 August 6, 2013 Blank et al.
8509867 August 13, 2013 Workman et al.
8515509 August 20, 2013 Bruinsma et al.
8523781 September 3, 2013 Al-Ali
8529301 September 10, 2013 Al-Ali et al.
8532727 September 10, 2013 Ali et al.
8532728 September 10, 2013 Diab et al.
D692145 October 22, 2013 Al-Ali et al.
8547209 October 1, 2013 Kiani et al.
8548548 October 1, 2013 Al-Ali
8548549 October 1, 2013 Schurman et al.
8548550 October 1, 2013 Al-Ali et al.
8554297 October 8, 2013 Moon et al.
8560032 October 15, 2013 Al-Ali et al.
8560034 October 15, 2013 Diab et al.
8570167 October 29, 2013 Al-Ali
8570503 October 29, 2013 Vo et al.
8571617 October 29, 2013 Reichgott et al.
8571618 October 29, 2013 Lamego et al.
8571619 October 29, 2013 Al-Ali et al.
8577431 November 5, 2013 Lamego et al.
8581732 November 12, 2013 Al-Ali et al.
8584345 November 19, 2013 Al-Ali et al.
8588880 November 19, 2013 Abdul-Hafiz et al.
8597274 December 3, 2013 Sloan et al.
8600467 December 3, 2013 Al-Ali et al.
8606342 December 10, 2013 Diab
8622902 January 7, 2014 Woehrle
8626255 January 7, 2014 Al-Ali et al.
8630691 January 14, 2014 Lamego et al.
8634889 January 21, 2014 Al-Ali et al.
8641631 February 4, 2014 Sierra et al.
8652060 February 18, 2014 Al-Ali
8663107 March 4, 2014 Kiani
8666468 March 4, 2014 Al-Ali
8667967 March 11, 2014 Al-Ali et al.
8670811 March 11, 2014 O'Reilly
8670814 March 11, 2014 Diab et al.
8676286 March 18, 2014 Weber et al.
8682407 March 25, 2014 Al-Ali
RE44823 April 1, 2014 Parker
RE44875 April 29, 2014 Kiani et al.
8688183 April 1, 2014 Bruinsma et al.
8690799 April 8, 2014 Telfort et al.
8700112 April 15, 2014 Kiani
8702627 April 22, 2014 Telfort et al.
8706179 April 22, 2014 Parker
8712494 April 29, 2014 Macneish, III et al.
8715206 May 6, 2014 Telfort et al.
8718735 May 6, 2014 Lamego et al.
8718737 May 6, 2014 Diab et al.
8718738 May 6, 2014 Blank et al.
8720249 May 13, 2014 Al-Ali
8721541 May 13, 2014 Al-Ali et al.
8721542 May 13, 2014 Al-Ali et al.
8723677 May 13, 2014 Kiani
8740792 June 3, 2014 Kiani et al.
8754776 June 17, 2014 Poeze et al.
8755535 June 17, 2014 Telfort et al.
8755856 June 17, 2014 Diab et al.
8755872 June 17, 2014 Marinow
8761850 June 24, 2014 Lamego
8764671 July 1, 2014 Kiani
8768423 July 1, 2014 Shakespeare et al.
8771204 July 8, 2014 Telfort et al.
8777634 July 15, 2014 Kiani et al.
8781543 July 15, 2014 Diab et al.
8781544 July 15, 2014 Al-Ali et al.
8781549 July 15, 2014 Al-Ali et al.
8788003 July 22, 2014 Schurman et al.
8790268 July 29, 2014 Al-Ali
8792949 July 29, 2014 Baker, Jr.
8801613 August 12, 2014 Al-Ali et al.
8821397 September 2, 2014 Al-Ali et al.
8821415 September 2, 2014 Al-Ali et al.
8830449 September 9, 2014 Lamego et al.
8831700 September 9, 2014 Schurman et al.
8838196 September 16, 2014 Mannheimer
8840549 September 23, 2014 Al-Ali et al.
8847740 September 30, 2014 Kiani et al.
8849365 September 30, 2014 Smith et al.
8852094 October 7, 2014 Al-Ali et al.
8852115 October 7, 2014 Muir
8852994 October 7, 2014 Wojtczuk et al.
8868147 October 21, 2014 Stippick et al.
8868150 October 21, 2014 Al-Ali et al.
8870792 October 28, 2014 Al-Ali et al.
8886271 November 11, 2014 Kiani et al.
8888539 November 18, 2014 Al-Ali et al.
8888708 November 18, 2014 Diab et al.
8892180 November 18, 2014 Weber et al.
8897847 November 25, 2014 Al-Ali
8909310 December 9, 2014 Lamego et al.
8911377 December 16, 2014 Al-Ali
8912909 December 16, 2014 Al-Ali et al.
8920317 December 30, 2014 Al-Ali et al.
8921699 December 30, 2014 Al-Ali et al.
8922382 December 30, 2014 Al-Ali et al.
8929964 January 6, 2015 Al-Ali et al.
8942777 January 27, 2015 Diab et al.
8948834 February 3, 2015 Diab et al.
8948835 February 3, 2015 Diab
8956294 February 17, 2015 McCombie et al.
8961416 February 24, 2015 Siddiqui et al.
8965471 February 24, 2015 Lamego
8983564 March 17, 2015 Al-Ali
8989831 March 24, 2015 Al-Ali et al.
8996085 March 31, 2015 Kiani et al.
8998809 April 7, 2015 Kiani
9028407 May 12, 2015 Bennett-Guerrero
9028429 May 12, 2015 Telfort et al.
9037207 May 19, 2015 Al-Ali et al.
9060721 June 23, 2015 Reichgott et al.
9066666 June 30, 2015 Kiani
9066680 June 30, 2015 Al-Ali et al.
9072474 July 7, 2015 Al-Ali et al.
9078560 July 14, 2015 Schurman et al.
9084569 July 21, 2015 Weber et al.
9095316 August 4, 2015 Welch et al.
9106038 August 11, 2015 Telfort et al.
9107625 August 18, 2015 Telfort et al.
9107626 August 18, 2015 Al-Ali et al.
9113831 August 25, 2015 Al-Ali
9113832 August 25, 2015 Al-Ali
9119595 September 1, 2015 Lamego
9131881 September 15, 2015 Diab et al.
9131882 September 15, 2015 Al-Ali et al.
9131883 September 15, 2015 Al-Ali
9131917 September 15, 2015 Telfort et al.
9138180 September 22, 2015 Coverston et al.
9138182 September 22, 2015 Al-Ali et al.
9138192 September 22, 2015 Weber et al.
9142117 September 22, 2015 Muhsin et al.
9153112 October 6, 2015 Kiani et al.
9153121 October 6, 2015 Kiani et al.
9161696 October 20, 2015 Al-Ali et al.
9161713 October 20, 2015 Al-Ali et al.
9167995 October 27, 2015 Lamego et al.
9176141 November 3, 2015 Al-Ali et al.
9186102 November 17, 2015 Bruinsma et al.
9192312 November 24, 2015 Al-Ali
9192329 November 24, 2015 Al-Ali
9192351 November 24, 2015 Telfort et al.
9195385 November 24, 2015 Al-Ali et al.
9211072 December 15, 2015 Kiani
9211095 December 15, 2015 Al-Ali
9218454 December 22, 2015 Kiani et al.
9226696 January 5, 2016 Kiani
9241662 January 26, 2016 Al-Ali et al.
9245668 January 26, 2016 Vo et al.
9259185 February 16, 2016 Abdul-Hafiz et al.
9267572 February 23, 2016 Barker et al.
9277880 March 8, 2016 Poeze et al.
9289167 March 22, 2016 Diab et al.
9295421 March 29, 2016 Kiani et al.
9307928 April 12, 2016 Al-Ali et al.
9323894 April 26, 2016 Kiani
D755392 May 3, 2016 Hwang et al.
9326712 May 3, 2016 Kiani
9333316 May 10, 2016 Kiani
9339220 May 17, 2016 Lamego et al.
9341565 May 17, 2016 Lamego et al.
9351673 May 31, 2016 Diab et al.
9351675 May 31, 2016 Al-Ali et al.
9364181 June 14, 2016 Kiani et al.
9368671 June 14, 2016 Wojtczuk et al.
9370325 June 21, 2016 Al-Ali et al.
9370326 June 21, 2016 McHale et al.
9370335 June 21, 2016 Al-Ali et al.
9375185 June 28, 2016 Ali et al.
9386953 July 12, 2016 Al-Ali
9386961 July 12, 2016 Al-Ali et al.
9392945 July 19, 2016 Al-Ali et al.
9397448 July 19, 2016 Al-Ali et al.
9408542 August 9, 2016 Kinast et al.
9436645 September 6, 2016 Al-Ali et al.
9445759 September 20, 2016 Lamego et al.
9466919 October 11, 2016 Kiani et al.
9474474 October 25, 2016 Lamego et al.
9480422 November 1, 2016 Al-Ali
9480435 November 1, 2016 Olsen
9492110 November 15, 2016 Al-Ali et al.
9510779 December 6, 2016 Poeze et al.
9517024 December 13, 2016 Kiani et al.
9532722 January 3, 2017 Lamego et al.
9538949 January 10, 2017 Al-Ali et al.
9538980 January 10, 2017 Telfort et al.
9549696 January 24, 2017 Lamego et al.
9554737 January 31, 2017 Schurman et al.
9560996 February 7, 2017 Kiani
9560998 February 7, 2017 Al-Ali et al.
9566019 February 14, 2017 Al-Ali et al.
9579039 February 28, 2017 Jansen et al.
9591975 March 14, 2017 Dalvi et al.
9622692 April 18, 2017 Lamego et al.
9622693 April 18, 2017 Diab
D788312 May 30, 2017 Al-Ali et al.
9636055 May 2, 2017 Al-Ali et al.
9636056 May 2, 2017 Al-Ali
9649054 May 16, 2017 Lamego et al.
9662052 May 30, 2017 Al-Ali et al.
9668679 June 6, 2017 Schurman et al.
9668680 June 6, 2017 Bruinsma et al.
9668703 June 6, 2017 Al-Ali
9675286 June 13, 2017 Diab
9687160 June 27, 2017 Kiani
9693719 July 4, 2017 Al-Ali et al.
9693737 July 4, 2017 Al-Ali
9697928 July 4, 2017 Al-Ali et al.
9717425 August 1, 2017 Kiani et al.
9717458 August 1, 2017 Lamego et al.
9724016 August 8, 2017 Al-Ali et al.
9724024 August 8, 2017 Al-Ali
9724025 August 8, 2017 Kiani et al.
9730640 August 15, 2017 Diab et al.
9743887 August 29, 2017 Al-Ali et al.
9749232 August 29, 2017 Sampath et al.
9750442 September 5, 2017 Olsen
9750443 September 5, 2017 Smith et al.
9750461 September 5, 2017 Telfort
9775545 October 3, 2017 Al-Ali et al.
9775546 October 3, 2017 Diab et al.
9775570 October 3, 2017 Al-Ali
9778079 October 3, 2017 Al-Ali et al.
9782077 October 10, 2017 Lamego et al.
9782110 October 10, 2017 Kiani
9787568 October 10, 2017 Lamego et al.
9788735 October 17, 2017 Al-Ali
9788768 October 17, 2017 Al-Ali et al.
9795300 October 24, 2017 Al-Ali
9795310 October 24, 2017 Al-Ali
9795358 October 24, 2017 Telfort et al.
9795739 October 24, 2017 Al-Ali et al.
9801556 October 31, 2017 Kiani
9801588 October 31, 2017 Weber et al.
9808188 November 7, 2017 Perea et al.
9814418 November 14, 2017 Weber et al.
9820691 November 21, 2017 Kiani
9833152 December 5, 2017 Kiani et al.
9833180 December 5, 2017 Shakespeare et al.
9839379 December 12, 2017 Al-Ali et al.
9839381 December 12, 2017 Weber et al.
9847002 December 19, 2017 Kiani et al.
9847749 December 19, 2017 Kiani et al.
9848800 December 26, 2017 Lee et al.
9848806 December 26, 2017 Al-Ali et al.
9848807 December 26, 2017 Lamego
9861298 January 9, 2018 Eckerbom et al.
9861304 January 9, 2018 Al-Ali et al.
9861305 January 9, 2018 Weber et al.
9867578 January 16, 2018 Al-Ali et al.
9872623 January 23, 2018 Al-Ali
9876320 January 23, 2018 Coverston et al.
9877650 January 30, 2018 Muhsin et al.
9877686 January 30, 2018 Al-Ali et al.
9891079 February 13, 2018 Dalvi
9895107 February 20, 2018 Al-Ali et al.
9913617 March 13, 2018 Al-Ali et al.
9924893 March 27, 2018 Schurman et al.
9924897 March 27, 2018 Abdul-Hafiz
9936917 April 10, 2018 Poeze et al.
9943269 April 17, 2018 Muhsin et al.
9949676 April 24, 2018 Al-Ali
9955937 May 1, 2018 Telfort
9965946 May 8, 2018 Al-Ali
9980667 May 29, 2018 Kiani et al.
D820865 June 19, 2018 Muhsin et al.
9986919 June 5, 2018 Lamego et al.
9986952 June 5, 2018 Dalvi et al.
9989560 June 5, 2018 Poeze et al.
9993207 June 12, 2018 Al-Ali et al.
10007758 June 26, 2018 Al-Ali et al.
D822215 July 3, 2018 Al-Ali et al.
D822216 July 3, 2018 Barker et al.
10010276 July 3, 2018 Al-Ali et al.
10032002 July 24, 2018 Kiani et al.
10039482 August 7, 2018 Al-Ali et al.
10052037 August 21, 2018 Kinast et al.
10058275 August 28, 2018 Al-Ali et al.
10064562 September 4, 2018 Al-Ali
10086138 October 2, 2018 Novak, Jr.
10092200 October 9, 2018 Al-Ali et al.
10092249 October 9, 2018 Kiani et al.
10098550 October 16, 2018 Al-Ali et al.
10098591 October 16, 2018 Al-Ali et al.
10098610 October 16, 2018 Al-Ali et al.
10111591 October 30, 2018 Dyell et al.
D833624 November 13, 2018 DeJong et al.
10123726 November 13, 2018 Al-Ali et al.
10123729 November 13, 2018 Dyell et al.
10130289 November 20, 2018 Al-Ali et al.
10130291 November 20, 2018 Schurman et al.
D835282 December 4, 2018 Barker et al.
D835283 December 4, 2018 Barker et al.
D835284 December 4, 2018 Barker et al.
D835285 December 4, 2018 Barker et al.
10149616 December 11, 2018 Al-Ali et al.
10154815 December 18, 2018 Al-Ali et al.
10159412 December 25, 2018 Lamego et al.
10188296 January 29, 2019 Al-Ali et al.
10188331 January 29, 2019 Al-Ali et al.
10188348 January 29, 2019 Kiani et al.
RE47218 February 5, 2019 Al-Ali
RE47244 February 19, 2019 Kiani et al.
RE47249 February 19, 2019 Kiani et al.
10194847 February 5, 2019 Al-Ali
10194848 February 5, 2019 Kiani et al.
10201298 February 12, 2019 Al-Ali et al.
10205272 February 12, 2019 Kiani et al.
10205291 February 12, 2019 Scruggs et al.
10213108 February 26, 2019 Al-Ali
10219706 March 5, 2019 Al-Ali
10219746 March 5, 2019 McHale et al.
10226187 March 12, 2019 Al-Ali et al.
10226576 March 12, 2019 Kiani
10231657 March 19, 2019 Al-Ali et al.
10231670 March 19, 2019 Blank et al.
10231676 March 19, 2019 Al-Ali et al.
RE47353 April 16, 2019 Kiani et al.
10251585 April 9, 2019 Al-Ali et al.
10251586 April 9, 2019 Lamego
10255994 April 9, 2019 Sampath et al.
10258265 April 16, 2019 Poeze et al.
10258266 April 16, 2019 Poeze et al.
10271748 April 30, 2019 Al-Ali
10278626 May 7, 2019 Schurman et al.
10278648 May 7, 2019 Al-Ali et al.
10279247 May 7, 2019 Kiani
10292628 May 21, 2019 Poeze et al.
10292657 May 21, 2019 Abdul-Hafiz et al.
10292664 May 21, 2019 Al-Ali
10299708 May 28, 2019 Poeze et al.
10299709 May 28, 2019 Perea et al.
10299720 May 28, 2019 Brown et al.
10305775 May 28, 2019 Lamego et al.
10307111 June 4, 2019 Muhsin et al.
10325681 June 18, 2019 Sampath et al.
10327337 June 18, 2019 Triman et al.
10327713 June 25, 2019 Barker et al.
10332630 June 25, 2019 Al-Ali
10335033 July 2, 2019 Al-Ali
10335068 July 2, 2019 Poeze et al.
10335072 July 2, 2019 Al-Ali et al.
10342470 July 9, 2019 Al-Ali et al.
10342487 July 9, 2019 Al-Ali et al.
10342497 July 9, 2019 Al-Ali et al.
10349895 July 16, 2019 Telfort et al.
10349898 July 16, 2019 Al-Ali et al.
10354504 July 16, 2019 Kiani et al.
10357206 July 23, 2019 Weber et al.
10357209 July 23, 2019 Al-Ali
10366787 July 30, 2019 Sampath et al.
10368787 August 6, 2019 Reichgott et al.
10376190 August 13, 2019 Poeze et al.
10376191 August 13, 2019 Poeze et al.
10383520 August 20, 2019 Wojtczuk et al.
10383527 August 20, 2019 Al-Ali
10388120 August 20, 2019 Muhsin et al.
10398320 September 3, 2019 Kiani et al.
10405804 September 10, 2019 Al-Ali
10413666 September 17, 2019 Al-Ali et al.
10420493 September 24, 2019 Al-Ali et al.
D864120 October 22, 2019 Forrest et al.
10433776 October 8, 2019 Al-Ali
10441181 October 15, 2019 Telfort et al.
10441196 October 15, 2019 Eckerbom et al.
10448844 October 22, 2019 Al-Ali et al.
10448871 October 22, 2019 Al-Ali
10456038 October 29, 2019 Lamego et al.
10463284 November 5, 2019 Al-Ali et al.
10463340 November 5, 2019 Telfort et al.
10470695 November 12, 2019 Al-Ali
10471159 November 12, 2019 Lapotko et al.
10478107 November 19, 2019 Kiani et al.
10503379 December 10, 2019 Al-Ali et al.
10505311 December 10, 2019 Al-Ali et al.
10512436 December 24, 2019 Muhsin et al.
10524706 January 7, 2020 Telfort et al.
10524738 January 7, 2020 Olsen
10531811 January 14, 2020 Al-Ali et al.
10531819 January 14, 2020 Diab et al.
10531835 January 14, 2020 Al-Ali et al.
10532174 January 14, 2020 Al-Ali
10537285 January 21, 2020 Sherim et al.
10542903 January 28, 2020 Al-Ali et al.
10548561 February 4, 2020 Telfort et al.
10555678 February 11, 2020 Dalvi et al.
10568514 February 25, 2020 Wojtczuk et al.
10568553 February 25, 2020 O'Neil et al.
RE47882 March 3, 2020 Al-Ali
10575779 March 3, 2020 Poeze et al.
10608817 March 31, 2020 Haider et al.
D880477 April 7, 2020 Forrest et al.
10617302 April 14, 2020 Al-Ali et al.
10617335 April 14, 2020 Al-Ali et al.
10637181 April 28, 2020 Al-Ali et al.
D887548 June 16, 2020 Abdul-Hafiz et al.
D887549 June 16, 2020 Abdul-Hafiz et al.
10667764 June 2, 2020 Ahmed et al.
D890708 July 21, 2020 Forrest et al.
10721785 July 21, 2020 Al-Ali
10736518 August 11, 2020 Al-Ali et al.
10750984 August 25, 2020 Pauley et al.
D897098 September 29, 2020 Al-Ali
10779098 September 15, 2020 Iswanto et al.
10827961 November 10, 2020 Iyengar et al.
10828007 November 10, 2020 Telfort et al.
10832818 November 10, 2020 Muhsin et al.
10849554 December 1, 2020 Shreim et al.
10856750 December 8, 2020 Indorf et al.
D906970 January 5, 2021 Forrest et al.
10918281 February 16, 2021 Al-Ali et al.
10932705 March 2, 2021 Muhsin et al.
10932729 March 2, 2021 Kiani et al.
10939878 March 9, 2021 Kiani et al.
D916135 April 13, 2021 Indorf et al.
D917550 April 27, 2021 Indorf et al.
D917564 April 27, 2021 Indorf et al.
D917704 April 27, 2021 Al-Ali et al.
10987066 April 27, 2021 Chandran et al.
10991135 April 27, 2021 Al-Ali et al.
D919094 May 11, 2021 Al-Ali et al.
D919100 May 11, 2021 Al-Ali et al.
11006867 May 18, 2021 Al-Ali
D921202 June 1, 2021 Al-Ali et al.
11024064 June 1, 2021 Muhsin et al.
11026604 June 8, 2021 Chen et al.
D925597 July 20, 2021 Chandran et al.
D927699 August 10, 2021 Al-Ali et al.
11076777 August 3, 2021 Lee et al.
11114188 September 7, 2021 Poeze et al.
20010034477 October 25, 2001 Mansfield et al.
20010039483 November 8, 2001 Brand et al.
20020010401 January 24, 2002 Bushmakin et al.
20020058864 May 16, 2002 Mansfield et al.
20020098807 July 25, 2002 Saarnimo
20020133080 September 19, 2002 Apruzzese et al.
20030013975 January 16, 2003 Kiani
20030018241 January 23, 2003 Mannheimer
20030018243 January 23, 2003 Gerhardt et al.
20030135087 July 17, 2003 Hickle et al.
20030144582 July 31, 2003 Cohen et al.
20030156288 August 21, 2003 Barnum et al.
20030212312 November 13, 2003 Coffin, IV et al.
20040106163 June 3, 2004 Workman, Jr. et al.
20040162499 August 19, 2004 Nagai et al.
20050027182 February 3, 2005 Siddiqui
20050038332 February 17, 2005 Saidara et al.
20050055276 March 10, 2005 Kiani et al.
20050177096 August 11, 2005 Bollish
20050234317 October 20, 2005 Kiani
20050240091 October 27, 2005 Lynn
20060073719 April 6, 2006 Kiani
20060189871 August 24, 2006 Al-Ali et al.
20060220881 October 5, 2006 Al-Ali
20070040692 February 22, 2007 Smith et al.
20070073116 March 29, 2007 Kiani et al.
20070156031 July 5, 2007 Sullivan
20070180140 August 2, 2007 Welch et al.
20070244377 October 18, 2007 Cozad et al.
20070282478 December 6, 2007 Al-Ali et al.
20080064965 March 13, 2008 Jay et al.
20080094228 April 24, 2008 Welch et al.
20080103375 May 1, 2008 Kiani
20080157980 July 3, 2008 Sachanandani et al.
20080162182 July 3, 2008 Cazares
20080183054 July 31, 2008 Kroeger et al.
20080221418 September 11, 2008 Al-Ali et al.
20080255438 October 16, 2008 Saidara
20080281168 November 13, 2008 Gibson
20080287756 November 20, 2008 Lynn
20090036759 February 5, 2009 Ault et al.
20090040874 February 12, 2009 Rooney
20090093687 April 9, 2009 Telfort et al.
20090095926 April 16, 2009 MacNeish, III
20090210163 August 20, 2009 Ochs et al.
20090247848 October 1, 2009 Baker, Jr.
20090247849 October 1, 2009 McCutcheon et al.
20090247851 October 1, 2009 Batchelder et al.
20090247924 October 1, 2009 Lamego et al.
20090247984 October 1, 2009 Lamego et al.
20090275807 November 5, 2009 Sitzman et al.
20090275813 November 5, 2009 Davis
20090275844 November 5, 2009 Al-Ali
20090299157 December 3, 2009 Telfort et al.
20090326340 December 31, 2009 Wang et al.
20100004518 January 7, 2010 Vo et al.
20100030040 February 4, 2010 Poeze et al.
20100099964 April 22, 2010 O'Reilly et al.
20100113904 May 6, 2010 Batchelder et al.
20100234718 September 16, 2010 Sampath et al.
20100261979 October 14, 2010 Kiani
20100270257 October 28, 2010 Wachman et al.
20110001605 January 6, 2011 Kiani et al.
20110028806 February 3, 2011 Merritt et al.
20110028809 February 3, 2011 Goodman
20110040197 February 17, 2011 Welch et al.
20110082711 April 7, 2011 Poeze et al.
20110087081 April 14, 2011 Kiani et al.
20110105854 May 5, 2011 Kiani et al.
20110118561 May 19, 2011 Tari et al.
20110125060 May 26, 2011 Telfort et al.
20110137297 June 9, 2011 Kiani et al.
20110172498 July 14, 2011 Olsen et al.
20110208015 August 25, 2011 Welch et al.
20110209915 September 1, 2011 Telfort et al.
20110213212 September 1, 2011 Al-Ali
20110230733 September 22, 2011 Al-Ali
20110237911 September 29, 2011 Lamego et al.
20110237969 September 29, 2011 Eckerbom et al.
20110288383 November 24, 2011 Diab
20120041316 February 16, 2012 Al Ali et al.
20120046557 February 23, 2012 Kiani
20120059267 March 8, 2012 Lamego et al.
20120088984 April 12, 2012 Al-Ali et al.
20120116175 May 10, 2012 Al-Ali et al.
20120123231 May 17, 2012 O'Reilly
20120165629 June 28, 2012 Merritt et al.
20120179006 July 12, 2012 Jansen et al.
20120209082 August 16, 2012 Al-Ali
20120209084 August 16, 2012 Olsen et al.
20120226117 September 6, 2012 Lamego et al.
20120227739 September 13, 2012 Kiani
20120232366 September 13, 2012 Kiani
20120265039 October 18, 2012 Kiani
20120283524 November 8, 2012 Kiani et al.
20120286955 November 15, 2012 Welch et al.
20120296178 November 22, 2012 Lamego et al.
20120319816 December 20, 2012 Al-Ali
20120330112 December 27, 2012 Lamego et al.
20130023775 January 24, 2013 Lamego et al.
20130041591 February 14, 2013 Lamego
20130045685 February 21, 2013 Kiani
20130046204 February 21, 2013 Lamego et al.
20130060108 March 7, 2013 Schurman et al.
20130060147 March 7, 2013 Welch et al.
20130096405 April 18, 2013 Garfio
20130096936 April 18, 2013 Sampath et al.
20130109935 May 2, 2013 Al-Ali et al.
20130162433 June 27, 2013 Muhsin et al.
20130190581 July 25, 2013 Al-Ali et al.
20130197328 August 1, 2013 Diab et al.
20130211214 August 15, 2013 Olsen
20130243021 September 19, 2013 Siskavich
20130253334 September 26, 2013 Al-Ali et al.
20130267804 October 10, 2013 Al-Ali
20130274571 October 17, 2013 Diab et al.
20130274572 October 17, 2013 Al-Ali et al.
20130296672 November 7, 2013 O'Neil et al.
20130296713 November 7, 2013 Al-Ali et al.
20130317370 November 28, 2013 Dalvi et al.
20130324808 December 5, 2013 Al-Ali et al.
20130331660 December 12, 2013 Al-Ali et al.
20130331670 December 12, 2013 Kiani
20130338461 December 19, 2013 Lamego et al.
20130345921 December 26, 2013 Al-Ali et al.
20140012100 January 9, 2014 Al-Ali et al.
20140025306 January 23, 2014 Weber et al.
20140034353 February 6, 2014 Al-Ali et al.
20140051952 February 20, 2014 Reichgott et al.
20140051953 February 20, 2014 Lamego et al.
20140051954 February 20, 2014 Al-Ali et al.
20140058230 February 27, 2014 Abdul-Hafiz et al.
20140066783 March 6, 2014 Kiani et al.
20140077956 March 20, 2014 Sampath et al.
20140081100 March 20, 2014 Muhsin et al.
20140081175 March 20, 2014 Telfort
20140094667 April 3, 2014 Schurman et al.
20140100434 April 10, 2014 Diab et al.
20140114199 April 24, 2014 Lamego et al.
20140120564 May 1, 2014 Workman et al.
20140121482 May 1, 2014 Merritt et al.
20140121483 May 1, 2014 Kiani
20140125495 May 8, 2014 Al-Ali
20140127137 May 8, 2014 Bellott et al.
20140128696 May 8, 2014 Al-Ali
20140128699 May 8, 2014 Al-Ali et al.
20140129702 May 8, 2014 Lamego et al.
20140135588 May 15, 2014 Al-Ali et al.
20140142401 May 22, 2014 Al-Ali et al.
20140142402 May 22, 2014 Al-Ali et al.
20140163344 June 12, 2014 Al-Ali
20140163402 June 12, 2014 Lamego et al.
20140166076 June 19, 2014 Kiani et al.
20140171763 June 19, 2014 Diab
20140180038 June 26, 2014 Kiani
20140180154 June 26, 2014 Sierra et al.
20140180160 June 26, 2014 Brown et al.
20140187973 July 3, 2014 Brown et al.
20140194709 July 10, 2014 Al-Ali et al.
20140194711 July 10, 2014 Al-Ali
20140194766 July 10, 2014 Al-Ali et al.
20140200420 July 17, 2014 Al-Ali
20140200422 July 17, 2014 Weber et al.
20140206963 July 24, 2014 Al-Ali
20140213864 July 31, 2014 Abdul-Hafiz et al.
20140243627 August 28, 2014 Diab et al.
20140266790 September 18, 2014 Al-Ali et al.
20140275808 September 18, 2014 Poeze et al.
20140275835 September 18, 2014 Lamego et al.
20140275871 September 18, 2014 Lamego et al.
20140275872 September 18, 2014 Merritt et al.
20140275881 September 18, 2014 Lamego et al.
20140276115 September 18, 2014 Dalvi et al.
20140288400 September 25, 2014 Diab et al.
20140296664 October 2, 2014 Bruinsma et al.
20140303520 October 9, 2014 Telfort et al.
20140309506 October 16, 2014 Lamego et al.
20140309507 October 16, 2014 Baker, Jr.
20140309559 October 16, 2014 Telfort et al.
20140316217 October 23, 2014 Purdon et al.
20140316218 October 23, 2014 Purdon et al.
20140316228 October 23, 2014 Blank et al.
20140323825 October 30, 2014 Al-Ali et al.
20140323897 October 30, 2014 Brown et al.
20140323898 October 30, 2014 Purdon et al.
20140330092 November 6, 2014 Al-Ali et al.
20140330098 November 6, 2014 Merritt et al.
20140330099 November 6, 2014 Al-Ali et al.
20140333440 November 13, 2014 Kiani
20140336481 November 13, 2014 Shakespeare et al.
20140343436 November 20, 2014 Kiani
20150005600 January 1, 2015 Blank et al.
20150011907 January 8, 2015 Purdon et al.
20150012231 January 8, 2015 Poeze et al.
20150018650 January 15, 2015 Al-Ali et al.
20150025406 January 22, 2015 Al-Ali
20150032029 January 29, 2015 Al-Ali et al.
20150038859 February 5, 2015 Dalvi et al.
20150045637 February 12, 2015 Dalvi
20150051462 February 19, 2015 Olsen
20150073241 March 12, 2015 Lamego
20150080754 March 19, 2015 Purdon et al.
20150087936 March 26, 2015 Al-Ali et al.
20150094546 April 2, 2015 Al-Ali
20150097701 April 9, 2015 Al-Ali et al.
20150099950 April 9, 2015 Al-Ali et al.
20150099951 April 9, 2015 Al-Ali et al.
20150099955 April 9, 2015 Al-Ali et al.
20150101844 April 16, 2015 Al-Ali et al.
20150106121 April 16, 2015 Muhsin et al.
20150112151 April 23, 2015 Muhsin et al.
20150116076 April 30, 2015 Al-Ali et al.
20150126830 May 7, 2015 Schurman et al.
20150133755 May 14, 2015 Smith et al.
20150141781 May 21, 2015 Weber et al.
20150165312 June 18, 2015 Kiani
20150196237 July 16, 2015 Lamego
20150216459 August 6, 2015 Al-Ali et al.
20150230755 August 20, 2015 Al-Ali et al.
20150238722 August 27, 2015 Al-Ali
20150245773 September 3, 2015 Lamego et al.
20150245794 September 3, 2015 Al-Ali
20150257689 September 17, 2015 Al-Ali et al.
20150272514 October 1, 2015 Kiani et al.
20150351697 December 10, 2015 Weber et al.
20150351704 December 10, 2015 Kiani et al.
20150359429 December 17, 2015 Al-Ali et al.
20150366472 December 24, 2015 Kiani
20150366507 December 24, 2015 Blank
20150374298 December 31, 2015 Al-Ali et al.
20150380875 December 31, 2015 Coverston et al.
20160000362 January 7, 2016 Diab et al.
20160007930 January 14, 2016 Weber et al.
20160029932 February 4, 2016 Al-Ali
20160045118 February 18, 2016 Kiani
20160051205 February 25, 2016 Al-Ali et al.
20160058338 March 3, 2016 Schurman et al.
20160058347 March 3, 2016 Reichgott et al.
20160066823 March 10, 2016 Al-Ali et al.
20160066824 March 10, 2016 Al-Ali et al.
20160066879 March 10, 2016 Telfort et al.
20160072429 March 10, 2016 Kiani et al.
20160081552 March 24, 2016 Wojtczuk et al.
20160095543 April 7, 2016 Telfort et al.
20160095548 April 7, 2016 Al-Ali et al.
20160103598 April 14, 2016 Al-Ali et al.
20160113527 April 28, 2016 Al-Ali et al.
20160143548 May 26, 2016 Al-Ali
20160166182 June 16, 2016 Al-Ali et al.
20160166183 June 16, 2016 Poeze et al.
20160166188 June 16, 2016 Bruinsma et al.
20160166210 June 16, 2016 Al-Ali
20160192869 July 7, 2016 Kiani et al.
20160196388 July 7, 2016 Lamego
20160197436 July 7, 2016 Barker et al.
20160213281 July 28, 2016 Eckerbom et al.
20160228043 August 11, 2016 O'Neil et al.
20160233632 August 11, 2016 Scruggs et al.
20160234944 August 11, 2016 Schmidt et al.
20160270735 September 22, 2016 Diab et al.
20160283665 September 29, 2016 Sampath et al.
20160287090 October 6, 2016 Al-Ali et al.
20160287786 October 6, 2016 Kiani
20160296169 October 13, 2016 McHale et al.
20160310052 October 27, 2016 Al-Ali et al.
20160314260 October 27, 2016 Kiani
20160324486 November 10, 2016 Al-Ali et al.
20160324488 November 10, 2016 Olsen
20160327984 November 10, 2016 Al-Ali et al.
20160328528 November 10, 2016 Al-Ali et al.
20160331332 November 17, 2016 Al-Ali
20160367173 December 22, 2016 Dalvi et al.
20170007134 January 12, 2017 Al-Ali et al.
20170007190 January 12, 2017 Al-Ali et al.
20170007198 January 12, 2017 Al-Ali et al.
20170014083 January 19, 2017 Diab et al.
20170014084 January 19, 2017 Al-Ali et al.
20170021099 January 26, 2017 Al-Ali et al.
20170024748 January 26, 2017 Haider
20170027456 February 2, 2017 Kinast et al.
20170042488 February 16, 2017 Muhsin
20170055847 March 2, 2017 Kiani et al.
20170055851 March 2, 2017 Al-Ali
20170055882 March 2, 2017 Al-Ali et al.
20170055887 March 2, 2017 Al-Ali
20170055896 March 2, 2017 Al-Ali et al.
20170079594 March 23, 2017 Telfort et al.
20170086723 March 30, 2017 Al-Ali et al.
20170143281 May 25, 2017 Olsen
20170147774 May 25, 2017 Kiani
20170156620 June 8, 2017 Al-Ali et al.
20170173632 June 22, 2017 Al-Ali
20170187146 June 29, 2017 Kiani et al.
20170188919 July 6, 2017 Al-Ali et al.
20170196464 July 13, 2017 Jansen et al.
20170196470 July 13, 2017 Lamego et al.
20170202490 July 20, 2017 Al-Ali et al.
20170224231 August 10, 2017 Al-Ali
20170224262 August 10, 2017 Al-Ali
20170228516 August 10, 2017 Sampath et al.
20170245790 August 31, 2017 Al-Ali et al.
20170251974 September 7, 2017 Shreim et al.
20170251975 September 7, 2017 Shreim et al.
20170258403 September 14, 2017 Abdul-Hafiz et al.
20170311891 November 2, 2017 Kiani et al.
20170325728 November 16, 2017 Al-Ali et al.
20170332976 November 23, 2017 Al-Ali et al.
20170340293 November 30, 2017 Al-Ali et al.
20170360310 December 21, 2017 Kiani et al.
20170367632 December 28, 2017 Al-Ali et al.
20180008146 January 11, 2018 Al-Ali et al.
20180013562 January 11, 2018 Haider et al.
20180014752 January 18, 2018 Al-Ali et al.
20180028124 February 1, 2018 Al-Ali et al.
20180055390 March 1, 2018 Kiani et al.
20180055430 March 1, 2018 Diab et al.
20180064381 March 8, 2018 Shakespeare et al.
20180070867 March 15, 2018 Smith et al.
20180082767 March 22, 2018 Al-Ali et al.
20180085068 March 29, 2018 Telfort
20180087937 March 29, 2018 Al-Ali et al.
20180103874 April 19, 2018 Lee et al.
20180103905 April 19, 2018 Kiani
20180125368 May 10, 2018 Lamego et al.
20180125430 May 10, 2018 Al-Ali et al.
20180125445 May 10, 2018 Telfort et al.
20180132769 May 17, 2018 Weber et al.
20180146901 May 31, 2018 Al-Ali et al.
20180146902 May 31, 2018 Kiani et al.
20180153442 June 7, 2018 Eckerbom et al.
20180153446 June 7, 2018 Kiani
20180153447 June 7, 2018 Al-Ali et al.
20180153448 June 7, 2018 Weber et al.
20180168491 June 21, 2018 Al-Ali et al.
20180184917 July 5, 2018 Kiani
20180192924 July 12, 2018 Al-Ali
20180192953 July 12, 2018 Shreim et al.
20180199871 July 19, 2018 Pauley et al.
20180206795 July 26, 2018 Al-Ali
20180206815 July 26, 2018 Telfort
20180213583 July 26, 2018 Al-Ali
20180214090 August 2, 2018 Al-Ali et al.
20180216370 August 2, 2018 Ishiguro et al.
20180218792 August 2, 2018 Muhsin et al.
20180225960 August 9, 2018 Al-Ali et al.
20180238718 August 23, 2018 Dalvi
20180242853 August 30, 2018 Al-Ali
20180242921 August 30, 2018 Muhsin et al.
20180242923 August 30, 2018 Al-Ali et al.
20180242926 August 30, 2018 Muhsin et al.
20180247353 August 30, 2018 Al-Ali et al.
20180247712 August 30, 2018 Muhsin et al.
20180256087 September 13, 2018 Al-Ali et al.
20180285094 October 4, 2018 Housel et al.
20180289325 October 11, 2018 Poeze et al.
20180296161 October 18, 2018 Shreim et al.
20180300919 October 18, 2018 Muhsin et al.
20180310822 November 1, 2018 Indorf et al.
20180310823 November 1, 2018 Al-Ali et al.
20180317826 November 8, 2018 Muhsin
20180317841 November 8, 2018 Novak, Jr.
20180333055 November 22, 2018 Lamego et al.
20180333087 November 22, 2018 Al-Ali
20190000317 January 3, 2019 Muhsin et al.
20190000362 January 3, 2019 Kiani et al.
20190015023 January 17, 2019 Monfre
20190029574 January 31, 2019 Schurman et al.
20190029578 January 31, 2019 Al-Ali et al.
20190058280 February 21, 2019 Al-Ali et al.
20190058281 February 21, 2019 Al-Ali et al.
20190069813 March 7, 2019 Al-Ali
20190069814 March 7, 2019 Al-Ali
20190076028 March 14, 2019 Al-Ali et al.
20190082979 March 21, 2019 Al-Ali et al.
20190090760 March 28, 2019 Kinast et al.
20190090764 March 28, 2019 Al-Ali
20190117070 April 25, 2019 Muhsin et al.
20190117139 April 25, 2019 Al-Ali et al.
20190117140 April 25, 2019 Al-Ali et al.
20190117141 April 25, 2019 Al-Ali
20190117930 April 25, 2019 Al-Ali
20190122763 April 25, 2019 Sampath et al.
20190133525 May 9, 2019 Al-Ali et al.
20190142283 May 16, 2019 Lamego et al.
20190142344 May 16, 2019 Telfort et al.
20190150856 May 23, 2019 Kiani et al.
20190167161 June 6, 2019 Al-Ali et al.
20190175019 June 13, 2019 Al-Ali et al.
20190192076 June 27, 2019 McHale et al.
20190200941 July 4, 2019 Chandran et al.
20190201623 July 4, 2019 Kiani
20190209025 July 11, 2019 Al-Ali
20190214778 July 11, 2019 Scruggs et al.
20190216319 July 18, 2019 Poeze et al.
20190216379 July 18, 2019 Al-Ali et al.
20190221966 July 18, 2019 Kiani et al.
20190223804 July 25, 2019 Blank et al.
20190231199 August 1, 2019 Al-Ali et al.
20190231241 August 1, 2019 Al-Ali et al.
20190231270 August 1, 2019 Abdul-Hafiz et al.
20190239787 August 8, 2019 Pauley et al.
20190239824 August 8, 2019 Muhsin et al.
20190254578 August 22, 2019 Lamego
20190261857 August 29, 2019 Al-Ali
20190269370 September 5, 2019 Al-Ali et al.
20190274606 September 12, 2019 Kiani et al.
20190274627 September 12, 2019 Al-Ali et al.
20190274635 September 12, 2019 Al-Ali et al.
20190290136 September 26, 2019 Dalvi et al.
20190298270 October 3, 2019 Al-Ali et al.
20190304601 October 3, 2019 Sampath et al.
20190304605 October 3, 2019 Al-Ali
20190307377 October 10, 2019 Perea et al.
20190320906 October 24, 2019 Olsen
20190320959 October 24, 2019 Al-Ali
20190320988 October 24, 2019 Ahmed et al.
20190325722 October 24, 2019 Kiani et al.
20190350506 November 21, 2019 Al-Ali
20190357812 November 28, 2019 Poeze et al.
20190357813 November 28, 2019 Poeze et al.
20190357823 November 28, 2019 Reichgott et al.
20190357824 November 28, 2019 Al-Ali
20190358524 November 28, 2019 Kiani
20190365294 December 5, 2019 Poeze et al.
20190365295 December 5, 2019 Poeze et al.
20190374135 December 12, 2019 Poeze et al.
20190374139 December 12, 2019 Kiani et al.
20190374173 December 12, 2019 Kiani et al.
20190374713 December 12, 2019 Kiani et al.
20190386908 December 19, 2019 Lamego et al.
20190388039 December 26, 2019 Al-Ali
20200000338 January 2, 2020 Lamego et al.
20200000415 January 2, 2020 Barker et al.
20200015716 January 16, 2020 Poeze et al.
20200021930 January 16, 2020 Iswanto et al.
20200029867 January 30, 2020 Poeze et al.
20200037453 January 30, 2020 Triman et al.
20200037891 February 6, 2020 Kiani et al.
20200037966 February 6, 2020 Al-Ali
20200046257 February 13, 2020 Eckerbom et al.
20200054253 February 20, 2020 Al-Ali et al.
20200060591 February 27, 2020 Diab et al.
20200060628 February 27, 2020 Al-Ali et al.
20200060629 February 27, 2020 Muhsin et al.
20200060869 February 27, 2020 Telfort et al.
20200074819 March 5, 2020 Muhsin et al.
20200111552 April 9, 2020 Ahmed
20200113435 April 16, 2020 Muhsin
20200113488 April 16, 2020 Al-Ali et al.
20200113496 April 16, 2020 Scruggs et al.
20200113497 April 16, 2020 Triman et al.
20200113520 April 16, 2020 Abdul-Hafiz et al.
20200138288 May 7, 2020 Al-Ali et al.
20200138368 May 7, 2020 Kiani et al.
20200163597 May 28, 2020 Dalvi et al.
20200196877 June 25, 2020 Vo et al.
20200253474 August 13, 2020 Muhsin et al.
20200253544 August 13, 2020 Belur Nagaraj et al.
20200275841 September 3, 2020 Telfort et al.
20200288983 September 17, 2020 Telfort et al.
20200321793 October 8, 2020 Al-Ali et al.
20200329983 October 22, 2020 Al-Ali et al.
20200329984 October 22, 2020 Al-Ali et al.
20200329993 October 22, 2020 Al-Ali et al.
20200330037 October 22, 2020 Al-Ali et al.
20210022628 January 28, 2021 Telfort et al.
20210104173 April 8, 2021 Pauley et al.
20210113121 April 22, 2021 Diab et al.
20210117525 April 22, 2021 Kiani et al.
20210118581 April 22, 2021 Kiani et al.
20210121582 April 29, 2021 Krishnamani et al.
20210161465 June 3, 2021 Barker et al.
20210236729 August 5, 2021 Kiani et al.
20210256267 August 19, 2021 Ranasinghe et al.
20210256835 August 19, 2021 Ranasinghe et al.
Foreign Patent Documents
0880936 December 1998 EP
0920729 April 2000 EP
H05228122 September 1993 JP
4777640 September 2011 JP
WO 96/15594 May 1996 WO
WO 99/13698 March 1999 WO
WO 00/42911 July 2000 WO
WO 00/44274 August 2000 WO
WO 03/007815 January 2003 WO
WO 03/028549 April 2003 WO
WO 2005/087097 September 2005 WO
WO 09/093159 July 2009 WO
WO 2009/093159 July 2009 WO
WO 2010/014743 February 2010 WO
Other references
  • US 9,579,050 B2, 02/2017, Al-Ali (withdrawn)
  • Jul. 10, 2020 Defendants Sotera Wireless, Inc. and Hon Hai Precision Industry Co. Ltd.'s Amended Local Patent Rule 4.1 Preliminary Claim Constructions with Extrinsic Evidence, and including Exhibits A-I, Masimo Corporation v. Sotera Wireless, Inc. and Hon Hai Precision Industry Co., Ltd., Case No. 3:19-cv-01100-BAS-NLS, 63 pages.
  • Jul. 24, 2020 Masimo Corporation's Responsive Claim Constructions and Extrinsic Evidence, and including Exhibit A, Masimo Corporation v. Sotera Wireless, Inc. and Hon Hai Precision Industry Co., Ltd., Case No. 3:19-cv-01100-BAS-NLS, 98 pages.
  • Jul. 24, 2020 Defendants Sotera Wireless, Inc. and Hon Hai Precision Industry Co. Ltd.'s Local Patent Rule 4.1 Preliminary Responsive Claim Constructions with Extrinsic Evidence, Masimo Corporation v. Sotera Wireless, Inc. and Hon Hai Precision Industry Co., Ltd., Case No. 3:19-cv-01100-BAS-NLS, 11 pages.
  • Aug. 10, 2020 Joint Hearing Statement, and including Exhibits 1-2 and Appendices A-I, Masimo Corporation v. Sotera Wireless, Inc. and Hon Hai Precision Industry Co., Ltd., Case No. 3:19-cv-01100-BAS-NLS, 480 pages.
  • Sep. 22, 2020 Plaintiff Masimo Corporation's Opening Claim Construction Brief, Masimo Corporation v. Sotera Wireless, Inc. and Hon Hai Precision Industry Co., Ltd., Case No. 3:19-cv-01100-BAS-NLS, 33 pages.
  • Sep. 22, 2020 Declaration of Jack Goldberg in Support of Plaintiff Masimo Corporation's Opening Claim Construction Brief, Masimo Corporation v. Sotera Wireless, Inc. and Hon Hai Precision Industry Co., Ltd., Case No. 3:19-cv-01100-BAS-NLS, 30 pages.
  • Sep. 22, 2020 Defendants Sotera Wireless, Inc. and Hon Hai Precision Industry Co., Ltd.'s Opening Markman Brief, Masimo Corporation v. Sotera Wireless, Inc. and Hon Hai Precision Industry Co., Ltd., Case No. 3:19-cv-01100-BAS-NLS, 33 pages.
  • Sep. 22, 2020 Declaration of Dr. George Yanulis in Support of Defendants' Opening Claim Construction Brief, Masimo Corporation v. Sotera Wireless, Inc. and Hon Hai Precision Industry Co., Ltd., Case No. 3:19-cv-01100-BAS-NLS, 64 pages.
  • Definition of “initiate”, excerpt from New Oxford American Dictionary, Third Edition, 2010, 4 pages.
  • Definition of “initiate”, excerpt from The New Oxford American Dictionary, 2001, 6 pages.
  • Dec. 7, 2020 Decision Granting Institution of Inter Partes Review, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, 51 pages.
  • International Search Report for PCT/US2009/052146, dated Dec. 15, 2009.
  • International Preliminary Report on Patentability and Written Opinion for PCT/US2009/052146 dated Feb. 10, 2011.
  • Rheineck-Leyssius, MD, et al., “Advanced Pulse Oximeter Signal Processing Technology Compared to Simple Averaging. I. Effect on Frequency of Alarms in the Operating Room”, Journal of Clinical Anesthesia, The Netherlands, May 1999, vol. 11, pp. 192-195.
  • Cust, AE, et al., “Alarm settings for the Marquette 8000 pulse oximeter to prevent hyperoxic and hypoxic episodes”, Journal Paediatric Child Health, 1999, vol. 35, pp. 159-162.
  • Lawless, Stephen T., “Crying wolf: False alarms in a pediatric intensive care unit”, Critical Care Medicine, 1994, vol. 22, No. 6, pp. 981-985.
  • Informal Expert Report of Dr. Stephen Barker, Lead Case No. 16-05968-LT11, executed Feb. 10, 2017.
  • Impact of Clinical Alarms On Patient Safety, ACCE Healthcare Technology Foundation, 2006, 20 pages.
  • Taenzer, M.D., Andreas, “Impact of Pulse Oximetry Surveillance on Rescue Events and Intensive Care Unit Transfers”, The American Society of Anesthesiologists, Inc., Feb. 2010, vol. 112, No. 2, pp. 282-287.
  • Stefanescu, MD MSc, Beatrice, “Improved Filtering of Pulse Oximeter Monitoring Alarms in the Neonatal ICU: Bedside Significance”, Respiratory Care, Jan. 2016, vol. 61, No. 1, pp. 85-89.
  • Rheineck-Leyssius, A.T., et al., “Influence of pulse oximeter lower alarm limit on the incidence of hypoxaemia in the recovery room”, British Journal of Anaesthesia, 1997, vol. 79, pp. 460-464.
  • Rheineck-Leyssius, MD, Aart, et al., “Influence of Pulse Oximeter Settings on the Frequency of Alarms, and Detection of Hypoxemia”, Journal of Clinical Monitoring and Computing, 1998, vol. 14, pp. 151-156.
  • Pan, MD., Peter, “Intraoperative Pulse Oximetry: Frequency and Distribution of Discrepant Data”, Journal of Clinical Monitoring and Computing, Nov./Dec. 1994, vol. 6, pp. 491-495.
  • Graham, Kelly, et al., Monitor Alarm Fatigue: Standardizing Use of Physiological Monitors and Decreasing Nuisance Alarms, American Journal of Critical Care, Jan. 2010, vol. 19, No. 1, pp. 27-37.
  • Barker, PhD, MD, Steven, “‘Motion-Resistant’ Pulse Oximetry: A Comparison of New and Old Models” Department of Anesthesiology, 2002, vol. 95, pp. 967-972.
  • National Patient Safety Goals Effective Jan. 1, 2015, Hospital Accreditation Program, The Joint Commission, Jan. 2015, pp. 1-17.
  • Brostowicz, Heather, et al. Oxygen saturation monitoring in the Neonatal Intensive Care Unit (NICU): Evaluation of a new alarm management, Journal of Neonatal-Perinatal Medicine 3, 2010, pp. 135-139.
  • Kowalczyk, Liz, “Patient alarms often unheard, unheeded” The Boston Globe, Feb. 13, 2011, in 5 pages.
  • Taenzer, Andreas, et al., “Postoperative Monitoring—The Dartmouth Experience”, The Official Journal of the Anesthesia Patient Safety Foundation, Spring-Summer 2012, vol. 27, No. 1, pp. 1-28.
  • Tobin, Martin, “Principles and Practice of Intensive Care Monitoring”, 1998, in 30 pages.
  • Severinghaus, M.D., John, et al., Pulse Oximeter Failure Thresholds in Hypotension and Vasoconstriction, Anesthesiology, Sep. 1990, vol. 73, No. 3, pp. 532-537.
  • Pologe, Jonas A., “Pulse Oximetry: Technical Aspects of Machine Design”, International Anesthesiology Clinics, Advances in Oxygen Monitoring, Fall, 1987, vol. 25, No. 3, pp. 137-153.
  • Tremper, Ph.D., Kevin et al., “Pulse Oximetry”, Medical Intelligence Article, Anesthesiology, Jan. 1989, vol. 70, No. 1, pp. 98-108.
  • Bosque, PhD, Elena, “Symbiosis of nurse and machine through fuzzy logic: Improved specificity of a neonatal pulse oximeter alarm”, Dec. 1995, vol. 18, Issue 2, pp. 67-75.
  • Paine, MPH, Christine, et al., “Systematic review of physiologic monitor alarm characteristics and pragmatic interventions to reduce alarm frequency” J Hosp Med., Feb. 2017, vol. 11, No. 2, pp. 136-144.
  • Top 10 Technology Hazards for 2012, Guidance Article, Nov. 2011, www.ecri.org, pp. 358-373.
  • Top 10 Technology Hazards for 2013, Health Devices, ECRI Institute, Nov. 2012, reprinted from vol. 41, Issue 11, in 25 pages.
  • Top 10 Health Technology Hazards for 2014, Health Devices, ECRI Institute, Nov. 2013, www.ecri.org/2014hazards, 1 page.
  • Masimo Advanced Alarm Performance: An Evidence-Based Approach to Reduce False Alarms and Nuisance Alarms, 2010, in 8 pages.
  • Complaint for Patent Infringement, Masimo Corporation v. Sotera Wireless and Hon Hai Precision Industry Co., Ltd., Case No. 3:19-cv-01100-BAS-NLS, filed Jun. 12, 2019, in 385 pages.
  • Jun. 12, 2019 Complaint for Patent Infringement and Demand for Jury Trial, Masimo Corporation v. Sotera Wireless and Hon Hai Precision Industry Co., Ltd., Case No. 3:19-cv-01100-BAS-NLS, 385 pages. [Uploaded in 2 parts].
  • Oct. 3, 2019 Defendant Sotera Wireless, Inc.'s Answer to Plaintiff's Complaint for Patent Infringement, Masimo Corporation v. Sotera Wireless and Hon Hai Precision Industry Co., Ltd., Case No. 3:19-cv-01100-BAS-NLS, 26 pages.
  • Oct. 3, 2019 Defendant Hon Hai Precision Industry Co., Ltd.'s Notice of Motion and Motion Pursuant to Rule 12(b)(6) to Dismiss Plaintiff's Complaint, Masimo Corporation v. Sotera Wireless and Hon Hai Precision Industry Co., Ltd., Case No. 3:19-cv-01100-BAS-NLS, 3 pages.
  • Oct. 3, 2019 Defendant Hon Hai Precision Industry Co., Ltd.'s Memorandum of Points and Authorities in Support of Motion Pursuant to Rule 12(b)(6) to Dismiss Plaintiff's Complaint, Masimo Corporation v. Sotera Wireless and Hon Hai Precision Industry Co., Ltd., Case No. 3:19-cv-01100-BAS-NLS, 16 pages.
  • Oct. 24, 2019 Defendant Sotera Wireless, Inc.'s First Amended Answer to Plaintiff's Complaint for Patent Infringement and Demand for Jury Trial, Masimo Corporation v. Sotera Wireless and Hon Hai Precision Industry Co., Ltd., Case No. 3:19-cv-01100-BAS-NLS, 32 pages.
  • Ferrell, “Design and Construct Miniaturized Biosensor/Transmitter System,” Dept. of Physics, University of Tennessee, Jun. 1999, 77 pages.
  • Perng et al., “Acceleration Sensing Glove (ASG),” Berkeley Sensor & Actuator Center, University of California, Berkeley, Feb. 1999, 3 pages.
  • Raghunath et al., “User Interfaces for Applications on a Wrist Watch, Wearable Computing Platforms,” IBM TJ Watson Research Center, New York, US, Personal Ubiquitous Computing, vol. 6, issue 1, Feb. 2002, pp. 17-30.
  • Stein et al., “Development of a Commercially Successful Wearable Data Collection System,” Digest of Papers. Second International Symposium on Wearable Computers, Pittsburgh, PA, USA, Oct. 19-20, 1998, pp. 18-24.
  • Billinghurst et al., “Wearable Devices: New Ways to Manage Information,” Computer, vol. 32, No. 1, Jan. 1999, pp. 57-64.
  • Berggren, “Wireless communication in telemedicine using Bluetooth and IEEE 802.11b,” Department of Information Technology, Uppsala University, Sweden, Nov. 2001, 32 pages.
  • Adler, “A Cost-Effective Portable Telemedicine Kit for Use in Developing Countries,” Massachusetts Institute of Technology, May 2000, 96 pages.
  • Satava, et al., “The Physiologic Cipher at Altitude: Telemedicine and Real-Time Monitoring of Climbers on Mount Everest,” Telemedicine Journal and e-Health, vol. 6, No. 3, Feb. 2000, pp. 303-313.
  • Fricke et al., “Wireless Sensor Review,” Arthur D. Little, Inc., Cambridge, MA, Mar. 2001, 59 pages.
  • Haglund, “Bluetooth Software and Hardware Development,” Imperial College of Science, Technology and Medicine, University of London, Sep. 2001, 66 pages.
  • Bilstrup et al., “Bluetooth in Industrial Environment,” IEEE International Workshop on Factory Communication Systems, Feb. 2000, 9 pages.
  • Shoemake, “Wi-Fi (IEEE 802.11b) and Bluetooth: Coexistence Issues and Solutions for the 2.4 GHz ISM Band,” Texas Instruments, Feb. 2001, 18 pages.
  • Aljuaied, “Bluetooth Technology and Its Implementation in Sensing Devices,” Research Office Naval Postgraduate School, Monterey, CA, Sep. 2001, 75 pages.
  • Seruca et al., “Enterprise Information Systems VI,” Springer, Kluwer Academic Publishers, Mar. 2006, 334 pages.
  • Tsien, “TrendFinder: Automated Detection of Alarmable Trends,” Massachusetts Institute of Technology, Apr. 2000, 240 pages.
  • Tsien, “Reducing False Alarms in the Intensive Care Unit: A Systematic Comparison of Four Algorithms,” Proceedings of the AMIA Annual Fall Symposium, 1997, p. 894.
  • Myerson et al., “An Evaluation of Ventilator Monitoring Alarms,” Anaesthesia and Intensive Care, vol. 14, No. 2, May 1986, pp. 174-185.
  • Huang, “Intelligent Alarms: Allocating Attention Among Concurrent Processes,” Stanford University, Mar. 1999, 198 pages.
  • Mora et al., “Intelligent Patient Monitoring and Management Systems: A Review,” IEEE Engineering in Medicine and Biology Magazine, vol. 12, issue 4, Dec. 1993, pp. 23-33.
  • Zhang et al., “Prospective Trials of Intelligent Alarm Algorithms for Patient Monitoring,” Proceedings of the AMIA Symposium, 2001, p. 1068.
  • Malangi, “Simulation and mathematical notation of alarms unit for computer assisted resuscitation algorithm,” New Jersey Institute or Technology, Digital Commons @ NJIT, These 526, Fall 2003.
  • Schoenberg MD et al., “Making ICU Alarms Meaningful: A Comparison of Traditional vs. Trend-Based Algorithms,” Proceedings. AMIA Symposium, 1999, pp. 379-383.
  • Jones, “Autonomous Patient Monitoring with a Pressure Sensor Array,” Carleton University, Ontario, Canada, Sep. 2006, 185 pages.
  • Taenzer et al., “Impact of Pulse Oximetry Surveillance on Rescue Events and Intensive Care Unit Transfers: A Before-and-After Concurrence Study,” Anesthesiology—The Journal of the American Society of Anesthesiologists, Inc., vol. 112, No. 2, Feb. 2010, pp. 282-287.
  • Mar. 20, 2020 Defendants Sotera Wireless Inc. and Hon Hai Precision Industry Co. Ltd.'s Invalidity Contentions, Masimo Corporation v. Sotera Wireless, Inc. and Hon Hai Precision Industry Co., Ltd., Case No. 3:19-cv-01100-BAS-NLS, 5182 pages.
  • Apr. 3, 2020 Masimo Corporation's Preliminary Claim Constructions and Extrinsic Evidence, Masimo Corporation v. Sotera Wireless and Hon Hai Precision Industry Co., Ltd., Case No. 3:19-cv-01100-BAS-NLS, 13 pages.
  • Apr. 3, 2020 Defendants Sotera Wireless, Inc. and Hon Hai Precision Industry Co. Ltd.'s Local Patent Rule 4.1 Preliminary Claim Constructions with Extrinsic Evidence, and including Exhibits A-I, Masimo Corporation v. Sotera Wireless and Hon Hai Precision Industry Co., Ltd., Case No. 3:19-cv-01100-BAS-NLS, 63 pages.
  • Jun. 8, 2020 First Amended Complaint for Patent Infringement and Demand for Jury Trial (Exhibits 1-10 comprise publicly available or previously submitted documents and are not included herein for ease of transmission), Masimo Corporation v. Sotera Wireless and Hon Hai Precision Industry Co., Ltd., Case No. 3:19-cv-01100-BAS-NLS, 58 pages.
  • Jun. 22, 2020 Defendant Sotera Wireless, Inc.'s Answer to Plaintiff's First Amended Complaint for Patent Infringement and Demand for Jury Trial (Exhibits A-X comprise publicly available or previously submitted documents and are not included herein for ease of transmission), Masimo Corporation v. Sotera Wireless and Hon Hai Precision Industry Co., Ltd., Case No. 3:19-cv-01100-BAS-NLS, 39 pages.
  • Rheineck-Leyssius et al., “Influence of Pulse Oximeter Lower Alarm Limit on the Incidence of Hypoxaemia in the Recovery Room,” 79 British Journal of Anesthesia, 1997, pp. 460-464.
  • The Institute of Electrical and Electronics Engineers, Inc., “Part 11: Wireless LAN Medium Access Control (MAC) and Physical Layer (PHY) specifications: High-speed Physical Layer in the 5 GHZ Band,” IEEE Std 802.11a-1999, Supplement to IEEE Std 802.11-1999, Sep. 1999, 90 pages.
  • Mäkivirta et al., “Alarm-Inducing Variability in Cardiac Postoperative Data and the Effects of Prealarm Delay”, Journal of Clinical Monitoring, May 1994, vol. 10, No. 3, pp. 153-162.
  • Rheineck-Leyssius et al., “Influence of Pulse Oximeter Settings on the Frequency of Alarms and Detection of Hypoxemia”, Journal of Clinical Monitoring and Computing, Apr. 1998, vol. 14, No. 3, pp. 151-156.
  • Petition for Inter Partes Review of U.S. Pat. No. 10,213,108, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-00912, dated May 7, 2020, in 113 pages.
  • Declaration of George E. Yanulis, in support of Petition for Inter Partes Review of U.S. Pat. No. 10,213,108, Ex. 1003, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-00912, dated May 6, 2020, in 127 pages.
  • Petition for Inter Partes Review of U.S. Pat. No. 9,788,735, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-00954, dated May 18, 2020, in 126 pages.
  • Declaration of George E. Yanulis, in support of Petition for Inter Partes Review of U.S. Pat. No. 9,788,735, Ex. 1003, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-00954, dated May 18, 2020, in 163 pages.
  • Petition for Inter Partes Review of U.S. Pat. No. 9,795,300, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01015, dated May 29, 2020, in 109 pages.
  • Declaration of George E. Yanulis, in support of Petition for Inter Partes Review of U.S. Pat. No. 9,795,300, Ex. 1003, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01015, dated May 28, 2020, in 156 pages.
  • Petition for Inter Partes Review of U.S. Pat. No. 9,872,623, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01054, dated Jun. 5, 2020, in 123 pages.
  • Declaration of George E. Yanulis, in support of Petition for Inter Partes Review of U.S. Pat. No. 9,872,623, Ex. 1003, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01054, dated Jun. 5, 2020, in 182 pages.
  • Petition for Inter Partes Review of U.S. Pat. No. RE47,244, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-00967, dated May 21, 2020, in 112 pages.
  • Declaration of George E. Yanulis, in support of Petition for Inter Partes Review of U.S. Pat. No. RE47,244, Ex. 1003, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-00967, dated May 21, 2020, in 181 pages.
  • Petition for Inter Partes Review of U.S. Pat. No. RE47,353, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01019, dated May 29, 2020, in 111 pages.
  • Declaration of George E. Yanulis, in support of Petition for Inter Partes Review of U.S. Pat. No. RE47,353, Ex. 1003, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01019, dated May 28, 2020, in 190 pages.
  • Petition for Inter Partes Review of U.S. Pat. No. RE47,249, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01033, dated Jun. 3, 2020, in 111 pages.
  • Declaration of George E. Yanulis, in support of Petition for Inter Partes Review of U.S. Pat. No. RE47,249, Ex. 1003, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01033, dated Jun. 2, 2020, in 196 pages.
  • Petition for Inter Partes Review of U.S. Pat. No. RE47,218, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, dated Jun. 11, 2020, in 66 pages.
  • Declaration of George E. Yanulis, in support of Petition for Inter Partes Review of U.S. Pat. No. RE47,218, Ex. 1003, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, dated Jun. 10, 2020, in 69 pages.
  • Petition for Inter Partes Review of U.S. Pat. No. 10,255,994, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01082, dated Jun. 11, 2020, in 88 pages.
  • Declaration of George E. Yanulis, in support of Petition for Inter Partes Review of U.S. Pat. No. 10,255,994, Ex. 1003, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01082, dated Jun. 11, 2020, in 113 pages.
  • Jan. 24, 2020 Masimo Corporation's Infringement Contensions, Masimo Corporation v. Sotera Wireless and Hon Hai Precision Industry Co., Ltd., Case No. 3:19-cv-01100-BAS-NLS, 537 pages.
  • Sep. 8, 2020 Defendants Sotera Wireless Inc. and Hon Hai Precision Industry Co. Ltd.'s Amended LPR 3.3 Invalidity Contentions, and including Exhibits A-I, Masimo Corporation v. Sotera Wireless, Inc. and Hon Hai Precision Industry Co., Ltd., Case No. 3:19-cv-01100-BAS-NLS, 3151 pages.
  • Dec. 31, 2020 Second Amended Complaint for Patent Infringement and Demand for Jury Trial (redacted public version including publicly available exhibits), Masimo Corporation v. Sotera Wireless and Hon Hai Precision Industry Co., Ltd., Case No. 3:19-cv-01100-BAS-NLS, 725 pages. [uploaded in 5 parts].
  • Jan. 14, 2021 Defendant Sotera Wireless Inc.'s Answer to Plaintiff's Second Amended Complaint for Patent Infringement and Demand for Jury Trial, Masimo Corporation v. Sotera Wireless and Hon Hai Precision Industry Co., Ltd., Case No. 3:19-cv-01100-BAS-NLS, 53 pages.
  • Definitions of “oximetry,” “pulse oximetry,” and “invasive,” excerpt from Stedman's Medical Dictionary (27th ed.), 2000, 5 pages.
  • Definitions of “oximeter,” “pulse oximeter,” and “invasive,” excerpt from Dorland's Illustrated Medical Dictionary (30th ed.), 2003, 5 pages.
  • Definition of “port,” excerpt from Webster's New World College Dictionary (4th ed.), 2001, 4 pages.
  • Definition of “port,” excerpt from Webster's II New College Dictionary, 2001, 4 pages.
  • Definition of “port,” excerpt from Microsoft Computer Dictionary (5th ed.), 2002, 4 pages.
  • Jubran, “Pulse oximetry,” Critical Care 1999, vol. 3, No. 2, pp. R11-R17.
  • Kelleher, “Pulse Oximetry,” Journal of Clinical Monitoring, vol. 5, No. 1, Jan. 1989, pp. 37-62.
  • Westover et al., “Human Factors Analysis of an ICU,” Journal of Clinical Engineering, vol. 23, No. 2, Mar./Apr. 1998, pp. 110-116.
  • Parati et al., “Self blood pressure monitoring at home by wrist devices: a reliable approach?” Journal of Hypertension, vol. 20, No. 4, 2002, pp. 573-578.
  • Hardesty, “Clothed in Health,” MIT Technology Review, Jul. 1, 2001, last accessed Feb. 17, 2021, and retrieved from https://www.technologyreview.com/2001/07/01/235697/clothed-in-health, 9 pages.
  • Datex AS/3TM Anesthesia Monitor Operator's Manual, Jan. 1995, 399 pages. [Uploaded in 2 parts].
  • Gordon et al., “2012 Anthropometric Survey of U.S. Army Personnel: Methods and Summary Statistics,” U.S. Army Natick Soldier Research, Dec. 2014, 454 pages.
  • Printouts from apple.com and Samsung.com websites showing common smartphone specifications, last accessed Feb. 18, 2021, and retrieved from https://www.apple.com/iphone/compare/?device1=iphoneX&device2=iphone11&device3=iphone12, and https://www.samsung.com/global/galaxy/compare-smartphones/, 16 pages.
  • Datasheet for EPROM/ROM-Based 8-bit CMOS Microcontroller Series, PIC16C5X, Microchip Technology Inc., 2013, 192 pages.
  • Running Armband & Wristband Phone Holder, Forearm Armband Phone Holder, 360° Rotatable Armband for iPhone Samsung Galaxy Google Pixel, Cellphone Wristband Great for Hiking Biking Running, Amazon.com, printed May 12, 2021, and retrieved from https://www.amazon.com/Running-Armband-Wristband-Rotatable-Cellphone/dp/B08DJ2B6X5/, 2 pages.
  • Registration Interface—Selection and General Information, AT&T Co. Standard, Bell System Practices, Section 463-400-100, Issue 1, May 1978, 5 pages.
  • Registration Interface—Adapter Arrangements RJA1X, RJA2X, and RJA3X, AT&T Co. Standard, Bell System Practices, Section 463-400-100, Issue 2, May 1979, 6 pages.
  • Modular Connector Guide, C2G, printed May 12, 2021, and retrieved from https://www.cablestogo.com/learning/connector-guides/modular, 3 pages.
  • IEEE Standard for a High Performance Serial Bus—Amendment 1, IEEE Std 1394a-2000 (Amendment to IEEE Std 1394-1995), The Institute of Electrical and Electronics Engineers, Inc., Mar. 30, 2000, 204 pages.
  • Kästle et al., “A New Family of Sensors for Pulse Oximetry,” Hewlett-Packard Journal, Article 7, Feb. 1997, pp. 1-17.
  • Portzon Set of 2 Neoprene Dumbbell Hand Weights, Anti-Slip, Anti-roll, Amazon.com, printed Feb. 22, 2021, and retrieved from https://www.amazon.com/Neoprene-Dumbbell-Weights-Anti-slip-Anti-roll/dp/B088M26WRH/, 9 pages.
  • JG Webster, ed., Design of Pulse Oximeter, Medical Science Series, IOP Publishing Ltd, 1997, 256 pages. [Uploaded in 4 parts].
  • Invicta Men's Pro Diver Scuba Quartz Chronograph Carbon Fiber Bezel Abalone Dial Bracelet Watch, 50mm, Amazon.com, printed May 17, 2021, and retrieved from https://www.amazon.com/Invicta-Quartz-Chronograph-Abalone-Bracelet/dp/B0772D8BWK/, 6 pages.
  • Data sheet for iKey Rugged Wearable Keyboard, Product Code AK-39, last accessed Jun. 17, 2021, and retrieved from https://www.ikey.com/document//?route=product/pdf&product_id=46, 2 pages.
  • Anderson, The Importance of Thomas Edison, Lucent Books, Inc., 1994, pp. 30-33.
  • Jun. 11, 2020 Sotera Wireless, Inc.'s Power of Attorney, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 3 pages.
  • Jun. 16, 2020 Notice of Filing Date Accorded to Petition, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 6 pages.
  • Jul. 2, 2020 Patent Owner Submission of Mandatory Notice Information, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 6 pages.
  • Sep. 16, 2020 Patent Owner Preliminary Response, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 49 pages.
  • Oct. 7, 2020 Order—Conduct of the Proceeding, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, 3 pages.
  • Oct. 7, 2020 Notice of Decision in Related Judicial Matter, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 3 pages.
  • Oct. 7, 2020 Patent Owner Updated Exhibit List, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 4 pages.
  • Oct. 16, 2020 Petitioner's Reply to Preliminary Response, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 12 pages.
  • Oct. 23, 2020 Patent Owner Sur-Reply re Fintiv Factors, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 11 pages.
  • Dec. 7, 2020 Decision Granting Institution of Inter Partes Review, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 51 pages.
  • Dec. 7, 2020 Scheduling Order, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 11 pages.
  • Dec. 21, 2020 Patent Owner Objections to Evidence, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, 7 pages.
  • Jan. 26, 2021 Sotera's Updated Mandatory Notices, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 4 pages.
  • Jan. 28, 2021 Masimo's Notice of Deposition of George Yanulis, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 3 pages.
  • Feb. 1, 2021 Sotera_s Updated Power of Attorney, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 3 pages.
  • Feb. 2, 2021 Masimo's Unopposed Motion for DCK to Appear Pro Hac Vice, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 7 pages.
  • Feb. 4, 2021 Order Granting Masimo's Unopposed Motion for DCK to Appear Pro Hac Vice, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 4 pages.
  • Feb. 9, 2021 Masimo's Updated Mandatory Notice Information Adding Back-Up Counsel, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 6 pages.
  • Feb. 9, 2021 Masimo's Supplemental Power of Attorney Adding DCK, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 3 pages.
  • Mar. 5, 2021 Masimo's Updated Mandatory Notice Information Adding Back-Up Counsel, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 6 pages.
  • Mar. 5, 2021 Patent Owner Response, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 69 pages.
  • Mar. 29, 2021 Sotera's Notice of Deposition of Jack Goldberg, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 4 pages.
  • May 28, 2021 Sotera's Reply, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 28 pages.
  • Jun. 8, 2021 Masimo's Objections to Evidence, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 5 pages.
  • Jul. 9, 2021 Patent Owner Sur-Reply, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 30 pages.
  • Jul. 30, 2021 Sotera's Request for Oral Argument, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 4 pages.
  • Jul. 30, 2021 Masimo's Request for Oral Argument, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 4 pages.
  • Aug. 3, 2021 Order Setting Oral Argument for Sep. 24, 2021, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 9 pages.
  • Aug. 20, 2021 Order Re-Setting Oral Argument for Sep. 24, 2021 at 2pm, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 5 pages.
  • Sep. 16, 2021 Masimo's Demonstratives for Oral Argument, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 59 pages.
  • Sep. 16, 2021 Sotera;s Oral Hearing Demonstratives, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 40 pages.
  • Sep. 20, 2021 Petitioner's Notice re Demonstratives for Oral Argument, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 43 pages.
  • Sep. 20, 2021 Patent Owner Updated Exhibit List, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, in 4 pages.
  • Masimo Opposition to Sotera Motion to Stay Proceedings, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 2001, in 22 pages.
  • Case Management Order, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 2002, in 8 pages.
  • Order Granting Joint Motion to Modify Case Management Order, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 2003, in 3 pages.
  • Mar. 20, 2020 Defendants' Invalidity Contentions, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 2004, in 38 pages.
  • Sep. 8, 2020 Defendants' Amended Invalidity Contentions, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 2007, in 43 pages.
  • Joint Hearing Statement, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 2008, in 23 pages.
  • Oct. 6, 2020 Order Granting in Part Joint Motion to Modify Case Management Order, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 2009, in 4 pages.
  • DCK Declaration ISO PHV Motion, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 2010, in 4 pages.
  • Declaration of Jack Goldberg, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 2011, in 52 pages.
  • Oxford Dictionary of English (2010)—Threshold, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 2012, in 3 pages.
  • American Heritage Dictionary (2011)—Threshold, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 2013, in 3 pages.
  • Yanulis Transcript, Feb. 10, 2021 vol. 6, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 2014, in 223 pages.
  • Jack Goldberg CV Feb. 22, 2021, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 2015, in 21 pages.
  • Patent Owner Demonstratives, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 2016, in 59 pages.
  • Prosecution History of RE47,218, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 1002, in 310 pages, uploaded in 2 parts.
  • Declaration of George E. Yanulis, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 1003, in 69 pages.
  • CV of George E. Yanulis, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 1004, in 8 pages.
  • Masimo's Complaint for Patent Infringement (Masimo v. Sotera, 19cv01100), Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 1008, in 44 pages.
  • Service of Summons and Complaint upon Sotera (Masimo v. Sotera, 19cv01100), Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 1009, in 4 pages.
  • RE218 Prosecution History Excerpt, Application with Preliminary Amendment, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 1010, in 55 pages.
  • RE218 Prosecution History Excerpt, Non-Final Office Action, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 1011, in 45 pages.
  • RE218 Prosecution History Excerpt, Amendment and Response to Office Action, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 1012, in 10 pages.
  • RE218 Prosecution History Excerpt, Notice of Allowance, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 1013, in 14 pages.
  • '570 Prosecution History Excerpt, Notice of Allowance, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 1015, in 49 pages.
  • Masimo Corporation's Infringement Contentions with Exhibit D (Masimo v. Sotera, 19cv0), Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 1016, in 36 pages.
  • Masimo's Trade Secret Complaint against Sotera in Orange County, CA, Superior Court, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 1017, in 20 pages.
  • Oral Ruling in Prior Trade Secret Litigation, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 1018, in 1 page.
  • Final Order in Prior Trade Secret Litigation, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 1019, in 117 pages.
  • Sotera Motion to Stay, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 1036, in 29 pages.
  • Order Vacating Claim Construction Hearing, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 1037, in 1 page.
  • Defendants' Stipulation of Invalidity Contentions, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 1038, in 10 pages.
  • Declaration of Bryan Bergeron ISO Sotera's Reply to Petition, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 1040, in 35 pages.
  • Bryan Bergeron CV, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 1041, in 40 pages.
  • Apr. 22, 2021 Deposition Transcript of Jack Goldberg, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 1042, in 106 pages.
  • Macmillan English Dictionary, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, Exhibit 1043, in 3 pages.
  • Nov. 29, 2021, Judgment Final Written Decision Determining All Challenged Claims Unpatentable, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, 77 pages.
  • Jan. 25, 2022 Patent Owner's Notice of Appeal to the U.S. Court of Appeals for the Federal Circuit, Sotera Wireless, Inc. v. Masimo Corporation, Inter Partes Review No. IPR2020-01078, 83 pages.
  • US 9,579,050, 02/2017, Al-Ali (withdrawn).
  • US 8,845,543, Diab et al. (withdrawn).
  • Coetzee, et al., “Noise-Resistant Pulse Oximetry Using a Synthetic Reference Signal,” IEEE Transactions on Biomedical Engineering, IEEE Service Center, Piscataway, NJ, vol. 47, No. 8, dated Aug. 1, 2000.
  • Invitation to Pay Additional Fees document, including communication relating to the results of a partial Search Report issued in related application No. PCT/US2011/026545, dated Jun. 22, 2011, in 5 pages.
  • “Propaq Encore Vital Signs Monitor: Reference Guide,” Welch Allyn, Inc., 2009 in 144 pages.
Patent History
Patent number: RE49007
Type: Grant
Filed: Feb 25, 2020
Date of Patent: Apr 5, 2022
Assignee: MASIMO CORPORATION (Irvine, CA)
Inventor: Ammar Al-Ali (San Juan Capistrano, CA)
Primary Examiner: Robert L Nasser
Application Number: 16/800,971
Classifications
Current U.S. Class: Diagnostic Testing (600/300)
International Classification: A61B 5/00 (20060101); A61B 5/1455 (20060101); G08B 29/26 (20060101);